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We studied how obesogenic conditions during various life periods affected obesity and intestinal tumorigenesis in adult C57BL/6J-
Min (multiple intestinal neoplasia)/+ mice. The mice were given a 10% fat diet throughout life (negative control) or a 45% fat diet
in utero, during nursing, during both in utero and nursing, during adult life, or during their whole life-span, and terminated at
11 weeks for tumorigenesis (Min/+) or 23 weeks for obesogenic effect (wild-type). Body weight at 11 weeks was increased after a
45% fat diet during nursing, during both in utero and nursing, and throughout life, but had normalized at 23 weeks. In the glucose
tolerance test, the early exposure to a 45% fat diet in utero, during nursing, or during both in utero and nursing, did not affect blood
glucose, whereas a 45% fat diet given to adults or throughout life did. However, a 45% fat diet during nursing or during in utero
and nursing increased the number of small intestinal tumors. So did exposures to a 45% fat diet in adult life or throughout life,
but without increasing the tumor numbers further. The intrauterine and nursing period is a window of susceptibility for dietary
fat-induced obesity and intestinal tumor development.
1. Introduction
Obesity is defined as an excess accumulation of adipose
tissue. The rate of obesity has more than doubled over the
past 20 years in most OECD countries [1]. More than half of
the adult population are overweight (with body mass index
(BMI) 25–30 kg/m2) or obese (with BMI ≥30 kg/m2), and
about 18% of both genders are obese. Rates of overweight and
obesity among children are also increasing; average reported
overweight rates (including obesity) increased from 13% in
2001-2002 to 15% in 2009-2010 for 15-year-olds (based on
age- and gender-specific cut-off points for BMI) [1]. Maternal
obesity during pregnancy is also a serious health issue with a
prevalence of obese adult women close to 30% in many of the
OECD countries [2].
A parallel increase in overweight/obesity andmany forms
of cancer has been observed in most countries around the
world in the past two to three decades. Cancer is now the
second leading cause of mortality in the OECD countries
[1]. In Norway, colon cancer is the second most prevalent
cancer for women, after breast cancer, and the third most
prevalent cancer for men, after prostrate and lung cancer
[3]. Overweight and/or obesity are associated with increased
risk, incidence, mortality, or poor prognosis for many
types of cancer, including colon cancer [4–7]. Body fatness
and abdominal fatness are both evaluated as convincing
increasing risks of colorectal cancer [8, 9]. Obesity may
be a contributing risk factor for increased susceptibility to
environmental contaminants causing cancer.
The rapid rise of obesity is suggested to be driven
mainly by environmental factors. Although it has been
much focus on the role of the current diet whether as
an obese child or adult, recent insights have also stressed
the importance of nutrition during very early life in the
development of metabolic disorders. The phenotype of an
individual can be driven by in utero and early postnatal
environmental conditions, determined by the nutritional
status of themother [10].This has given rise to the perception
Hindawi Publishing Corporation
Journal of Obesity
Article ID 624023
2 Journal of Obesity
of “developmental programming” and the concept “devel-
opmental origins of health and disease” (DOHaD). It is
proposed that conditions present during a critical window of
development can lead to permanent programmed alterations
in physiological systems and adverse outcomes later in life
[10, 11].
The “fetal origins of adult disease hypothesis” was orig-
inally put forward by David Barker and colleagues, which
stated that environmental factors, especially nutrition, act in
early life to program the risks for early onset of diseases such
as hypertension, diabetes, coronary heart disease, metabolic
disorders, and mental illnesses in adult life and premature
death [10–12]. Although the initial fetal origins hypothesis
was primarily concerned with undernutrition and malnutri-
tion, recent epidemiological and animals studies have begun
to examine the effects of overnutrition during critical periods
of fetal development and the offspring’s subsequent risk of
developing the same chronic diseases associated with fetal
growth restriction [13].
Maternal obesity is associated with numerous pregnancy-
related complications and risks for both mother and child
[14–16]. In addition to infertility, the mothers may have
increased risk from obesity for hypertensive disorders, coag-
ulopathies, gestational diabetes mellitus, respiratory com-
plications, pre-eclampsia, thromboembolism, and so forth,
in addition to miscarriage. The fetus has increased risk of
large-for-gestational-age size, congenital malformations or
perinatal mortality [14–16].
In this study, we have examined overnutrition, in the
form of a high fat diet, during various periods of life in
relation to the end points body weight and intestinal tumori-
genesis in the mice as adults, using the C57BL/6J-Min/+
(multiple intestinal neoplasia) mouse as the experimental
animal model. In addition, the wild-type (+/+) siblings were
used to examine the effects on bodyweight and organweights
in older mice.
The Min/+ mouse is heterozygous for a germline non-
sense mutation in the tumor suppressor gene adenomatous
polyposis coli (Apc) leading to a truncated nonfunctional
APC protein, and therefore develop numerous spontaneous
intestinal tumors [17, 18]. Apc is a key component in the Wnt
signaling pathway [19, 20]. TheMinmouse is a model for the
inherited disorder familial adenomatous polyposis (FAP), as
well as for sporadic colorectal cancer, in humans [21–23], and
develops multiple adenomas in the small intestine and to a
lesser degree in the colon.
In addition to the effects on spontaneous intestinal
tumors caused by the inherited mutated Apc gene in the
Min/+ mice, the effect of obesity was also examined on
tumors induced by the environmental (dietary) factor formed
during cooking of meat and fish, the mutagenic, genotoxic
and carcinogenic heterocyclic amine 2-amino-1-methyl-6-
phenylimidazo[4,5-b]pyridine (PhIP) [24]. Previously, we
have reported that PhIP increased intestinal tumorigenesis
in adult C57BL/6J-Min/+ mice [25], and that the Min/+
mice were much more susceptible to PhIP if exposed neona-
tally [26, 27] than as young adults [25, 27]. Blood glucose
levels were measured and a glucose tolerance test (GTT)
was performed to study the hypothesis of disrupted blood
glucose regulation as a link between obesity and intestinal
tumorigenesis [28, 29]. The hormone leptin, which regulates
food intake and energy expenditure, as well as having effects
on immunity, including inflammation, and reproduction [30,
31], was measured in serum from the mice.
In this study, we have examined during which periods
of life does exposure to obesogenic conditions in the form
of a high fat diet have the most effect on body weight and
susceptibility to disease, that is, intestinal tumorigenesis, as
adults.
2. Materials and Methods
2.1. Mice. Female C57BL/6J-Apc+/+ (wild-type) mice were
mated with C57BL/6J-ApcMin/+ males, using proven breeders
having had a litter on a regular breeding diet (2018 Teklad
Global 18% Protein Rodent Diet from Harlan Industries Inc.,
Indianapolis, IN, USA) before the experimental litters on
special diets with 10% or 45% fat (described below). Both
females and males were bred at the Norwegian Institute
of Public Health, Oslo, Norway. C57BL/6J-ApcMin/+ males
were originally purchased from the Jackson Laboratory (Bar
Harbour, ME, USA). To minimize the genetic drift from
the colony at the Jackson Laboratory, both females and
males in the breeding stock at our institute have been
replaced regularly. Homozygous mutant ApcMin/Min (Apc−/−)
mice die during the embryonal stages [32]; therefore, only
two genotypes were obtainable from these crosses. The Min
mutationwas propagated throughmales to avoid interference
with pregnancy from any anemia caused by the intestinal
adenomas in females [17].
Genotyping of the offspring for the Apc gene was per-
formed with allele-specific polymerase chain reaction (PCR)
using DNA extracted from ∼2mm2 samples obtained by ear
puncture for identification of individual mice at weaning, as
described previously [33].
The mice were housed in air flow IVC racks (Innovive
Inc., San Diego, CA, USA) in 100% PET plastic disposable
cages on Nestpak Aspen 4HK bedding (Datesand Ltd.,
Manchester, UK) in a room with 12-h light/dark cycle, and
controlled humidity (55 ± 5%) and temperature (20–24∘C).
Diet and water were given ad libitum.
The experiment reported in this paper was performed
in conformity with the laws and regulations for animal
experiments in Norway and was approved by the National
Experimental Animal Board in Norway.
2.2. Experimental Diets. Diets of purified ingredients from
Research Diets Inc. (New Brunswick, NJ, USA) were used.
The D12451 diet, containing 20%, 35%, and 45% of kcal from
protein, carbohydrates, and fat, respectively, was used as a
high fat diet. The D12450H diet, containing 20%, 70%, and
10% of kcal from protein, carbohydrates, and fat, respectively,
was used as a matching control low fat diet. The amount of
sucrose was 17% of the calories in both diets. The high fat
diet had 4.73 kcal/g, whereas the low fat diet had 3.85 kcal/g;
that is, the high fat diet contained 22.9% more kcal per gram
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Figure 1: Experimental design. The mice were exposed to a 45% fat diet for combinations of three periods in life; (1) in utero, via the dams,
(2) from birth to weaning, via milk during nursing, or (3) from weaning at 3 weeks to termination at 11 weeks of age (for Min/+ mice) or
23 weeks (for wild-type mice), to determine the most susceptible exposure period for development of obesity and intestinal tumorigenesis
as adults. The effects of a 45% fat diet were studied on spontaneous tumorigenesis induced by the inherited mutation in the Apc gene and
on tumors induced by the the food mutagen and carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). The mice in two
experimental groups (marked with arrows) were given one s.c. injection of 25mg/kg body weight of PhIP on days 3–6 after birth. In total,
eight experimental groups were included in this experiment; a 10% fat diet throughout life as a negative control (10+10+10), a 45% fat diet in
utero (45+10+10), a 45% fat diet during the nursing period (10+45+10), a 45% fat diet both in utero and during nursing (45+45+10), exposed
to PhIP or not, a 45% fat diet as adults (10+10+45), or a 45% fat diet throughout life (45+45+45), exposed to PhIP or not.
diet. In order to avoid that the dietary treatmentwas unevenly
spread out in time, we gave the first dam 10% fat diet, the
second dam 45% fat diet, the third dam 10% fat diet, the forth
dam 45% fat diet, and so on. Similarly, the litters of offspring
were given either of the two diets after birth every other
time and after weaning every other time until the necessary
numbers in all experimental dietary groups were obtained
(Figure 1). The number of litters (given in parentheses) in
each treatment group was 10% fat diet throughout life (17),
45% fat diet in utero (17), 45% fat diet during the nursing
period (14), 45% fat diet in utero and during the nursing
period (19), 45% fat diet as adults (18), and 45% fat diet
throughout life (21). For the groups also given PhIP, the
number of litters was 45% fat diet in utero and during the
nursing period (17) and 45% fat diet throughout life (17). The
number ofmice in each treatment group is given in the figures
and tables for the various end points.
2.3. Dietary Carcinogen. 2-Amino-1-methyl-6-phenylimid-
azo[4,5-b]pyridine (PhIP) hydrochloride (CAS number
105650-23-5), catalogue number 163-15951, of >99% purity,
was purchased from Wako Chemicals GmbH, Neuss,
Germany. PhIP-HCl was dissolved in distilled water, and the
pH was adjusted to approximately 4.0.
2.4. Experimental Treatment of Mice. Themice were exposed
to a 10% fat control diet or a 45% fat diet during combinations
of three periods of life; (1) in utero, via the dams, (2) from
birth to weaning, via milk during nursing, and (3) from
weaning at 3 weeks to termination at 11 weeks of age (the
Min/+ mice) or 23 weeks (the wild-type mice), to determine
the most susceptible exposure period for development of
obesity and intestinal tumorigenesis as adults. The effects of
a high fat diet were studied on spontaneous tumorigenesis
induced by the inherited mutation in the Apc gene, and on
tumors induced by the the food mutagen and carcinogen
PhIP. The mice in two experimental groups were given one
s.c. injection of 25mg/kg body weight of PhIP on days 3–6
after birth. This dose of PhIP was chosen to give a suitable
number of tumors above the spontaneous level based on
previous experience [34]. In total, eight treatment groups
were included in this experiment (Figure 1). The number of
mice (n) in each treatment group is given for each end point
in the figure legends and tables.
Blood was sampled by cardiac puncture under anesthesia
with ZRF cocktail (containing 3.3mg zolazepam, 3.3mg
tiletamine, 0.5mg xylazine and 2.6 𝜇g fentanyl per mL 0.9%
NaCl) into Microvette serum/clot activator tubes (Sarstedt
AS, Ski, Norway), and serum was obtained for analysis of
the hormone leptin. Thereafter, the mice were sacrificed by
cervical dislocation.
2.5. Recording of Body Weight and Feed Intake. Body weight
of the dams was recorded at mating and weekly during the
pregnancy and lactation periods. Bodyweight of the offspring
was registered on day 3-4 after birth and thereafter weekly
fromweaning until termination of theMin/+mice at 11 weeks
of age, before onset of noticeable anemia caused by their
tumors. The wild-type mice were terminated at 23 weeks of
age, to study the effects on body weight and organ weights
at older age. However, the body weight of the wild-type mice
was also evaluated at 11 weeks of age, for comparison with the
Min/+ mice terminated at 11 weeks. Body weight data were
evaluated in three ways; as body weight at a specific age (at
11 weeks for the Min/+ mice and at 23 weeks for the wild-
type mice), terminal body mass index (BMI) (also at 11 weeks
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for the Min/+ mice and at 23 weeks for the wild-type mice),
and as body weight development expressed as area under the
curve (AUC).The AUC was calculated for the offspring from
age 3-4 days to week 11 (Min/+ and wild-type mice), and
from week 12 to 23 (wild-type mice), as well as for the dams
from mating to the end of pregnancy, using the trapezoidal
rule in SigmaPlot 12.3 (Systat Software Inc., San Jose, CA,
USA). Nasoanal length was also recorded at termination to
calculate BMI as body weight/nasoanal length2 (in g/cm2).
Feed intake wasmonitored by weighing feed in and out of the
cages weekly for the dams during the pregnancy and lactation
periods, and for the pups from weaning until termination.
2.6. Scoring of Small Intestinal and Colonic Tumors. Colon
and small intestine were removed separately, rinsed in ice-
cold phosphate buffered saline (PBS) and slit open along
the longitudinal axis. Intestinal tissues were then spread flat
between sheets of filter paper, and fixed for at least 48 h in
10% neutral buffered formalin prior to staining with 0.2%
methylene blue (Sigma-Aldrich Norway AS, Oslo, Norway).
Number, diameter and localization of tumors in small intes-
tine and colon were scored by transillumination in an inverse
light microscope at a magnification of ×20. The scoring was
done in order of consecutivemouse numbers unaware of their
treatment. Diameters of tumors were scored with an eyepiece
graticule. Tumor position along the intestines was registered
in cm from the stomach. For each experimental group,
incidence of tumors (number of mice with tumors/number
of mice in the group), tumor number (mean number of
tumors/mouse ± SD) and tumor diameter in mm (mean of
all tumors in all mice in the group ± SD) were calculated,
for small intestine and colon separately. In addition, the size
of the tumors was illustrated by curves of distributions of
tumor size classes (of 0.25mm tumor diameter intervals),
calculated asmean number of tumors in each tumor size class
for each treatment group.These curves were used to illustrate
the effects of a 45% fat diet for various periods, which were
calculated by subtracting themean number of tumors inmice
exposed to the control diet with 10% fat throughout life from
the mean number of tumors in mice exposed to a 45% fat
diet for various periods (Figure 10(a)). It was also done to
illustrate the effect of PhIP on tumor size, by subtracting the
mean tumor numbers in the corresponding dietary groups
not exposed to PhIP from the mean number of tumors in the
PhIP-treated groups (Figure 10(b)).
2.7. Absolute andRelativeOrganWeights. The liver and spleen
were dissected and weighed at termination, and the data are
presented as absolute weight (in gram), or as relative weight
(in %) calculated as absolute weight/body weight × 100.
2.8. Blood Glucose Measurements and Glucose Tolerance
Test (GTT). Nonfasted blood glucose was measured with a
glucometer (FreeStyle Freedom Lite, Abbott Diabetes Care,
Inc., Alameda, CA, USA) in all the mice by puncture of the
saphenous vein in the hind leg at two time points: at age 6 and
11 weeks (Min/+ mice) and at age 6 and 23 weeks (wild-type
mice).
The glucose tolerance test (GTT) was performed on a
subset of mice from each treatment group when they were 10
weeks old. The mice were fasted for 6 h from approximately
9 a.m. to 3 p.m. before i.p. injection of 2 g/kg body weight
D-(+) glucose (Sigma-Aldrich, Norway, AS, Oslo). Blood
glucose wasmeasured 5min before and 15, 30, 60 and 120min
after injection of glucose.The AUCwas calculated from −5 to
120min with the trapezoidal rule using Sigmaplot 12.3.
When readings were above 27.8mmol/L and displaying
HIGH on the glucometer, this value was used in the data
analysis.This was not registered in any of the nonfasted blood
glucose samples. In GTT, this occurred only for one Min/+
male given a 45% fat diet as adult at the 15min time point,
and for one Min/+ female given a 45% fat diet throughout
life and PhIP, at 60min. No samples in either end point had
glucose readings below 1.1mmol/L and showing LOW in the
glucometer.
2.9. Leptin ELISA. The hormone leptin was measured in
serum obtained from the mice at sacrifice. An ELISA kit
(catalogue numberMBS455345) fromMyBioSource Inc. (San
Diego, CA, USA) was used according to the manufacturer’s
instructions. Optical density (OD) was measured at 450 nm
on a BioTek microplate reader (BioTek Instruments Inc.,
Winooski, VT, USA). Concentrations were calculated from
standard curves on each plate. All samples were diluted 1 : 20
in PBS, pH 7.1. The limit of detection was 0.06 ng leptin/mL.
2.10. Statistical Analyses. The data are presented as mean ±
SD and were analysed using SigmaPlot 12.3. The incidence
of colonic tumors was analysed by Fischer exact test (two-
tailed probability). For evaluation of all other data, analysis
of variance (ANOVA) was used with an appropriate multiple
comparison procedure. When testing the influence of a
single factor, one-way ANOVA with the Holm-Sidak test for
multiple comparisons was used for parametric data or the
Kruskal-Wallis ANOVA on ranks with Dunn’s test for mul-
tiple comparisons was used for nonparametric data. When
testing the influence of two or three factors together the data
were analysed by two- or three-way ANOVA, respectively,
with theHolm-Sidak test formultiple comparisons. A𝑃 value
of < 0.05 was considered statistically significant.
3. Results
3.1. The Dams’ Age When Mated. There were no statistically
significant differences between themean age atmating for the
dams given the various dietary combinations, being 121 days
(10+10+10, 𝑛 = 17), 108 days (45+10+10, 𝑛 = 17), 120 days
(10+45+10, 𝑛 = 14), 122 days (45+45+10, 𝑛 = 19), 114 days
(10+10+45, 𝑛 = 18), 104 days (45+45+45, 𝑛 = 21), 112 days
(45+45+10PhIP, 𝑛 = 17), and 105 days (45+45+45PhIP, 𝑛 =
17).There was a statistically significant difference (𝑃 = 0.046)
between the mean age at mating of all the dams given a 10%
fat versus a 45% fat diet, with mean age of 118 days (range 88–
170 days) for the dams on the 10% fat diet and 110 days (range
82–186) on the 45% fat diet. However, this small difference
most likely has no biological significance.
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Figure 2:The feed intake of the dams during (a) pregnancy, that is, frommating to the end of week 3 of pregnancy (𝑛 = 37–119), and (b) the
three week lactation period (𝑛 = 12–69), recorded as gram diet per gram body weight per week (mean ± SD). During pregnancy, the dams
were given either a 10% fat (white columns) or a 45% fat diet (black columns). The data for the lactation period were stratified according to
the four different combinations of the 10% fat or 45% fat diet during pregnancy and the 10% fat or 45% fat diets during the lactation period;
10+10+ (white columns), 45+10+ (light grey columns), 10+45+ (dark grey columns), 45+45+ (black columns), as explained in the legend to
Figure 1. (a) a,bSignificantly higher with a 10% fat diet versus a 45% fat diet within the same week. (b) a,b,cSignificantly higher with a 10% fat
diet during both pregnancy and nursing periods versus a 45% fat diet in the same periods within the same week. (b) d,eSignificantly higher
with a 45% fat diet during pregnancy and a 10% fat diet during nursing versus a 45% fat diet in both periods within the same week.
3.2. Breeding Efficiency on the Various Diets. There were
no statistically significant differences in the resulting mean
number of pups per litter in the various experimental dietary
groups, being 6.1 (10+10+10, 𝑛 = 17), 6.4 (45+10+10, 𝑛 = 17),
7.4 (10+45+10, 𝑛 = 14), 5.7 (45+45+10, 𝑛 = 19), 6.9 (10+10+45,
𝑛 = 18), 6.9 (45+45+45, 𝑛 = 21), 6.2 (45+45+10PhIP, 𝑛 = 17)
and 6.2 (45+45+45PhIP, 𝑛 = 17). Likewise, there were no
statistically significant differences in the mean number of
pups per litter between all litters given a 10% fat diet (6.8,
𝑛 = 49) or a 45% fat diet (6.3, 𝑛 = 91) during pregnancy.
3.3. Feed Intake of the Dams during Pregnancy. The feed
intake of the mice dams was recorded as gram feed per
gram body weight per week for each of the three weeks of
pregnancy (Figure 2(a)). The dams had a significantly higher
feed intake per gram body weight in both week 1 and 2
compared with week 3, of both the 10% fat and 45% fat diets
(𝑃 < 0.001 for all comparisons), and in week 1 comparedwith
week 2 for the 45% fat diet (𝑃 < 0.001).The intake of feed per
gram body weight was higher for the 10% fat diet than the
45% fat diet for all three weeks together, and for weeks 2 and
3 separately (𝑃 < 0.001 for all comparisons).
3.4. Feed Intake of the Dams during Nursing. The feed intake
of the mice dams was recorded as gram feed per gram body
weight per week for each of the three weeks of nursing
(Figure 2(b)). The dams in all dietary groups had a signif-
icantly higher feed intake in both week 2 and 3 compared
with week 1, and in week 3 compared with week 2, in all mice
and in each experimental dietary group separately (𝑃 values
were <0.001 to 0.012). The dams given a 45% fat diet during
pregnancy and lactation periods had significantly lower feed
intake than the dams given a 10% fat diet in both periods, in
all time periods together and in weeks 1, 2 and 3, separately
(𝑃 values were <0.001 to 0.018).The feed intake of the 45% fat
diet compared with the 10% fat diet fat diet was 18.3, 17.9 and
12.8% lower in week 1, 2 and 3, respectively. The dams given a
45% fat diet during both pregnancy and the lactation period
also had significantly lower feed intake than the dams given
a 45% fat diet during pregnancy and a 10% fat diet during
lactation, in all time periods together and in weeks 2 and 3,
separately (𝑃 values were <0.001 to 0.010).
3.5. Feed Intake of the Min/+ and Wild-Type Offspring Aged
4 to 11 Weeks. The feed intake of the mice offspring (Min/+
andwild-type combined) after weaningwas recorded as gram
feed per gram body weight per week for each experimental
group from week 4 to 11 for females (Figure 3(a)) and males
(data not shown) separately. In general, females had a higher
feed intake than males on gram body weight basis (𝑃 <
0.001), as has been found in our previous experiments (see
[33], Ngo et al., 2014; unpublished results). This was seen in
all treatment groups separately (𝑃 = 0.004 in the negative
control group and the group given 45% fat diet throughout
life and PhIP, and 𝑃 < 0.001 for the rest of the groups), and
in all weeks separately (𝑃 = 0.007 at week 4 and 𝑃 < 0.001
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Figure 3:The feed intake of the mice offspring after weaning was recorded as gram diet per gram body weight per week (mean ± SD) for each
experimental group (𝑛 = 10–27), shown for (a) femaleMin/+ and wild-type mice combined, from 4 to 11 weeks of age, and for (b) wild-type
males, from 12 to 23 weeks of age. Experimental dietary groups: 10+10+10 (open white columns), 45+10+10 (horizontally striped columns),
10+45+10 (cross-hatched columns), 10+10+45 (light grey columns), 45+45+10 (left upwards diagonally striped columns), 45+45+45 (dark
grey columns), 45+45+10 + PhIP (right upwards diagonally striped columns), 45+45+45 + PhIP (filled black columns), as explained in the
legend to Figure 1.
for the other weeks), except week 5 which did not reach
significance. There was a general decrease in feed intake per
gram body weight each week compared with the following
week (Figure 3(a)), which was statistically significant (𝑃
values were 0.018 to < 0.001) except for weeks 7–10.
Themice given a 45% fat diet either as adults (for 8 weeks)
or throughout life (for 11 weeks), with or without PhIP, had
significantly lower feed intake per gram body weight per
week than the other dietary groups receiving a 10% fat diet
throughout life (for 11 weeks), or a 45% fat diet for shorter
time, that is, only in utero (for 3 weeks), only during nursing
(for 3 weeks) or during in utero and nursing (for 6 weeks),
with or without PhIP (𝑃 values from 0.002 to < 0.001). PhIP
did not affect the feed intake.
3.6. Feed Intake of theWild-TypeOffspringAged 12 to 23Weeks.
The feed intake of the wild-type mice offspring was recorded
as gram feed per gram body weight per week for each
Journal of Obesity 7
experimental group from week 12 to 23 for females (data not
shown) and males (Figure 3(b)), separately. In general, wild-
type females had a higher feed intake than males on gram
body weight basis (𝑃 < 0.001), which was also seen in all
treatment groups separately and in all weeks separately (𝑃 <
0.001 for all comparisons). There was generally a higher feed
intake per gram body weight for the earlier weeks compared
with the later weeks (Figure 3(b)), which was statistically
significant in females for weeks 12, 14, 15 and 17 compared
with each of weeks 20–23, and for week 12 also comparedwith
weeks 18 and 19, and for week 15 also compared with week
19. Feed intake in week 16 was significantly higher compared
with weeks 21–23, and feed intake in week 13 and weeks 18–22
was significantly higher than in week 23 only (𝑃 values were
0.048 to < 0.001). In males, there was a significantly higher
feed intake in weeks 12 and 13 compared with each of weeks
20–23, and for weeks 14–22 compared with week 23 (𝑃 values
were 0.041 to < 0.001).
As observed for the Min/+ and wild-type mice at weeks
4–11, the wild-typemice of both genders at weeks 12–23 given
a 45% fat diet either as adults (for 8 weeks) or throughout life
(for 11 weeks), with or without PhIP, had significantly lower
feed intake per gram body weight per week than the other
dietary groups receiving a 10% fat diet throughout life (for 11
weeks), or a 45% fat diet for shorter time, that is, only in utero
(for 3 weeks), only during nursing (for 3 weeks) or during in
utero and nursing (for 6 weeks), with or without PhIP (𝑃 <
0.001 for all comparisons). PhIP did not affect the feed intake.
3.7. Body Weight of the Dams during Pregnancy in Gram or
as AUC. The increase in body weight in gram for the dams
on either a 10% fat or a 45% fat diet from mating until the
end of pregnancy is shown in Figure 4. The body weight
was significantly increased each week compared with the
previous week for dams on both 10% fat and 45% fat diets (𝑃
values were < 0.001 or 0.002 for all comparisons). The body
weight was significantly higher in the dams on a 45% fat diet
compared with a 10% fat diet at week 1 (3.3%, 𝑃 = 0.028)
and week 2 (7.2%, 𝑃 < 0.001) of pregnancy, but not at mating
(0.4%) and at week 3 at the end of pregnancy (2.0%).
Alsowhen calculating the increase in bodyweight asAUC
from mating until the end of pregnancy, the dams on a 45%
fat diet had significantly higher AUC than the dams on a 10%
fat diet (𝑃 = 0.018) (data not shown).
3.8. Body Weight in Min/+ and Wild-Type Mice Offspring in
Gram or as AUC from Day 3-4 to Week 11. Body weight
development (in gram) for both female and male Min/+
(Figure 5(a)) and wild-type (Figure 5(b)) mice of all treat-
ment groups is shown from age 3-4 days to 11 weeks. The
body weight development over time of themice offspring was
evaluated statistically as area under the curve (AUC) fromday
3-4 to week 11 for Min/+ (Figures 6(a) and 6(b)) and wild-
type (Figures 6(c) and 6(d)) mice for each dietary group.The
Min/+ mice had a lower AUC compared with the wild-type
mice in both females and males, and in mice both with and
without PhIP treatment (𝑃 < 0.001 for all comparisons).
Both Min/+ and wild-type male mice had larger AUC than
females (𝑃 < 0.001 both comparisons), which was apparent
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Figure 4: Body weight development (in gram) of dams during
pregnancy, that is, from mating to the end of week three of
pregnancy (mean ± SD).The dams were given either a 10% fat (open
circles) or a 45% fat (filled circles) diet in this period. 𝑛 = 41–123.
aSignificantly higher with a 45% fat diet versus a 10% fat diet in the
same week.
in all dietary groups (𝑃 < 0.001 for all comparisons). Min/+
mice exposed to PhIP had lower body weight than mice not
exposed to PhIP (𝑃 = 0.027), but PhIP did not affect the body
weight in the wild-type mice.
In both Min/+ and wild-type mice of both genders,
although slightly increased, exposure to a 45% fat diet in
utero did not significantly increase the body weight as AUC
compared with the negative control group given a 10% fat
diet throughout life. Exposure to a 45% fat diet only during
the nursing period significantly increased AUC compared
with the negative control group (𝑃 ≤ 0.009), except in
the subgroup male wild-type mice. However, exposure to a
45% fat diet both in utero and during nursing significantly
increased AUC compared with the negative control group
when evaluating both genotypes and genders together (𝑃 <
0.001), but only in the subgroup of males forMin/+ and wild-
type mice together (𝑃 = 0.010), whereas each genotype and
gender separately did not reach significance.The exposure to
a 45% fat diet during in utero and nursing did not increase
AUC further compared with a 45% diet only during nursing.
Thus, the effect of a 45% fat diet during the nursing period
is more efficient in increasing the body weight than the
exposure in utero.
The exposure to a 45% fat diet as adults did not increase
AUC compared with the control group or any of the other
exposure groups.The exposure to a 45% fat diet during nurs-
ing actually gave a significantly higher AUC than exposure
as adults in Min/+ male mice (𝑃 = 0.011). In both Min/+
and wild-type mice of both genders, the exposure to a 45%
fat diet throughout the whole life increased AUC compared
with the negative control group (𝑃 < 0.001), and this was
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Figure 5: Body weight development (in gram) of female and male mice of all treatment groups is illustrated for (a)Min/+ and (b) wild-type
mice from age 3-4 days to 11 weeks, and for (c) wild-type mice from age 12 to 23 weeks. The open white symbols are for untreated female
mice; 10+10+10 (I), 45+10+10 (△), 10+45+10 (󳶚), 45+45+10 (◻), 10+10+45 (◊), 45+45+45 (open hexagon), and the same filled black symbols
are for untreated male mice. The PhIP-treated groups are marked with grey symbols; 45+45+10 PhIP (I) and 45+45+45 PhIP (◻) in females,
and 45+45+10 PhIP (△), 45+45+45 PhIP (󳶚) in males. The experimental groups are as explained in the legend to Figure 1. 𝑛 = 20–46.
also the case for all subgroups; Min/+ females (𝑃 < 0.001),
Min/+ males (𝑃 = 0.001), wild-type females (𝑃 = 0.006)
and wild-type males (𝑃 < 0.001). Exposure to a 45% fat
diet throughout life also increased AUC compared with the
group given a 45% fat diet only in utero (𝑃 < 0.001), which
was seen in female (𝑃 = 0.024) and male (𝑃 < 0.001)
mice of both genotypes combined, and also in the subgroups
female Min/+ mice (𝑃 = 0.012) and male wild-type mice
(𝑃 < 0.001). Exposure to a 45% fat diet throughout life also
increased AUC compared with exposure both in utero and
during nursing (𝑃 < 0.001), which was seen in the female
(𝑃 = 0.024) and male (𝑃 = 0.030) mice of both genotypes
combined, and in the subgroup female Min/+ mice (𝑃 =
0.022). The comparison of a 45% fat diet throughout life with
the group given a 45% fat diet only during nursing did not
reach significance. However, AUC was significantly higher
after exposure to a 45% fat diet throughout life comparedwith
a 45% fat diet given only as adults (𝑃 < 0.001), which was
seen in female (𝑃 = 0.004) and male (𝑃 < 0.001) mice of
both genotypes combined, and also in the subgroups female
(𝑃 = 0.024) and male (𝑃 = 0.003) Min/+ mice, and male
(𝑃 < 0.001), but not female, wild-type mice.
Within the PhIP-exposed Min/+ mice, there was no
significant difference in AUC between the exposure to a
45% fat diet during in utero and nursing compared with
throughout life.
3.9. Body Weight in Wild-Type Mice Offspring in Gram or as
AUC fromWeek 12 to 23. TheMin/+mice were terminated at
11 weeks of age, before negative health effects of their tumors
become apparent. The wild-type mice were not terminated
until 23 weeks of age to study the impact of the early life
exposure to a 45% fat diet in older mice. The body weight
in gram of the wild-type mice from age 12 to 23 weeks is
illustrated in Figure 5(c).Thebodyweight development of the
wild-type mice offspring was evaluated statistically as AUC
from week 12 to week 23 for each dietary group (Figures 6(e)
and 6(f)).Themale wild-type mice were significantly heavier
than the females also at this age (𝑃 < 0.001). Similar to
the wild-type mice from day 3-4 to week 11, there was no
difference in AUC between wild-type mice given PhIP or left
untreated from week 12 to 23.
In the wild-type mice of both genders, although slightly
increased, exposure to the 45% fat diet only in utero did not
significantly increase the body weight as AUC from week 12
to 23 compared with the negative control group given a 10%
fat diet throughout life. The same was the case with exposure
to a 45% fat diet only during nursing, or during both in utero
and nursing. In wild-typemice, the exposure to a 45% fat diet
as adults or throughout life increased AUC from week 12 to
23 compared with the negative control group, both in females
(𝑃 = 0.033 and 𝑃 < 0.001) and in males (𝑃 < 0.001 for both
comparisons), respectively.
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Figure 6: Body weight development as AUC (arbitrary units, mean ± SD) from age 3-4 days to 11 weeks for (a) Min/+ females, (b) Min/+
males, (c) wild-type females and (d) wild-type males, and from age 12 to 23 weeks for (e) wild-type females and (f) wild-type males. The
experimental groups are as explained in the legend to Figure 1. 𝑛 = 20–46.
Exposure to a 45% fat diet as adults also increased AUC
compared with the group given a 45% fat diet only in utero,
and both in utero and during nursing, in males (𝑃 = 0.0013
and 𝑃 = 0.046, resp.), but not in females. Exposure to a 45%
fat diet throughout life also increased AUC compared with
exposure in utero, and in utero and during nursing, in females
(𝑃 = 0.008 and 𝑃 = 0.009, resp.), and in males (𝑃 < 0.001 for
both comparisons). Exposure to a 45% fat diet throughout life
also increased AUC compared with exposure only during the
nursing period in males (𝑃 < 0.001), but not in females. The
AUC results were not significantly different between a 45%
fat diet as adults or throughout life in either gender.
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Thus, the effects of an early exposure to a 45% fat diet
both in utero and during nursing, or only during nursing, on
AUC observed at age 3-4 days to 11 weeks, were no longer
present when the wild-type mice had reached the age of 12 to
23 weeks.
3.10. Body Weight in Min/+ and Wild-Type Mice Offspring
at a Specific Age (Week 11). Body weight at 11 weeks of age
was evaluated for both Min/+ (Figure 5(a)) and wild-type
mice (Figure 5(b)) of both genders. The Min/+ mice had
significantly lower terminal body weight than the wild-type
mice (𝑃 < 0.001). This was observed in the subgroups
untreated mice (𝑃 = 0.002), PhIP-treated mice (𝑃 < 0.001),
and in females (𝑃 < 0.001) and males (𝑃 < 0.001),
separately. Male mice had significantly higher body weight
at termination at 11 weeks compared with the female mice,
in Min/+ mice, in wild-type mice, in untreated and PhIP-
treated mice, and in all dietary groups (𝑃 < 0.001 for all
comparisons).
Based on all mice and Min/+ mice separately, mice
exposed to PhIP had a significantly lower terminal body
weight compared with the untreated mice (𝑃 < 0.001 for
both comparisons), but this was not seen in wild-type mice
separately. PhIP affected body weight in both female (𝑃 =
0.033) and male Min/+ mice (𝑃 < 0.001), separately. This
was also seen in the subgroups given 45% fat diet in utero
and during nursing (𝑃 = 0.019) and throughout life (𝑃 <
0.001). Apparently, the tumor burden in the Min/+ mice,
which is increased further with PhIP exposure, affects their
body weight negatively, before overt signs of anemia and
other negative health effects were observed. The same results
were also observed in a previous studywith thismousemodel
(Ngo et al., 2014; unpublished results).
Based on both Min/+ and wild-type mice, a 45% fat
diet given in utero did not increase terminal body weight
comparedwith the 10% control diet, whereas exposure during
the nursing period only (𝑃 < 0.001) or during both in utero
and nursing period (𝑃 = 0.032) did. In Min/+ or wild-type
mice separately, a 45% fat diet given in utero, or during both
in utero and nursing period, did not increase the bodyweight,
whereas exposure during only the nursing period did (𝑃 =
0.045 forMin/+ mice, and 𝑃 = 0.033 for wild-type mice). In
female and male mice separately, none of these comparisons
reached significance.
Based on both Min/+ and wild-type mice, exposure to
a 45% fat diet only as adults increased the body weight
compared with a 10% fat diet (𝑃 = 0.012), but not compared
with exposure to a 45% fat diet in utero, during nursing,
or during both in utero and nursing, whereas none of these
comparisons reached significance in Min/+ and wild-type
mice separately, or in female and male mice separately.
A 45% fat diet given throughout life to Min/+ and wild-
type mice combined, or both genotypes separately, gave a
significantly higher body weight compared with the negative
control group given a 10% fat diet throughout life (𝑃 < 0.001
for all comparisons). Exposure to a 45% fat diet throughout
life to the Min/+ and wild-type mice combined also had
significantly higher body weight compared with all the other
dietary groups (𝑃 values from 0.013 to < 0.01). This was also
seen in Min/+ and wild-type mice separately (𝑃 values from
0.037 to < 0.01), except that in these cases the comparison
with the mice given a 45% fat diet during nursing did not
reach significance. A 45% fat diet throughout life gave a
higher body weight in the subgroup female Min/+ mice
comparedwith a 45% fat diet in utero (𝑃 = 0.035) and in utero
and during nursing (𝑃 = 0.002), and in male wild-type mice
compared with a 45% fat diet in utero (𝑃 < 0.001), in utero
and during nursing (𝑃 = 0.046), and as adults (𝑃 = 0.019).
In the PhIP-treated Min/+ mice, a 45% fat diet given
throughout life did not give significantly higher body weight
compared with exposure to a 45% fat diet only in utero or
during nursing, as it did in the untreated Min/+ mice (𝑃 <
0.001).
The 45% fat diet throughout life gave significantly higher
body weight than the exposure to a 45% fat diet only in adult
life (𝑃 < 0.001, 𝑃 = 0.004 and 𝑃 = 0.0022, in all mice, and
Min/+mice and wild-type mice, resp.).
3.11. BodyWeight inWild-TypeMice Offspring at a Specific Age
(Week 23). The body weight of the wild-type mice from age
12 to 23 weeks is illustrated in Figure 5(c). Similar to the AUC
results in wild-type mice from day 3-4 to week 11 and from
week 12 to 23, there was no difference in terminal bodyweight
at week 23 betweenmice given PhIP or left untreated. In these
wild-type mice of both genders, although slightly increased,
exposure to a 45% fat diet only in utero did not significantly
increase terminal body weight at week 23 compared with
the negative control group given a 10% fat diet throughout
life. The same was the case with exposure to a 45% fat diet
only during nursing, or both in utero and during nursing.
The exposure to a 45% fat diet as adults or throughout life
increased terminal bodyweight at week 23 comparedwith the
negative control group, in both females and males separately
(𝑃 < 0.001 for all comparisons).
Exposure to a 45% fat diet as adults increased terminal
body weight compared with the group given 45% fat diet
in utero, and both in utero and during nursing, in females
(𝑃 = 0.043 and 𝑃 = 0.040, resp.), and in males (𝑃 < 0.001
and 𝑃 = 0.006, resp.), and compared with a 45% fat diet
only during nursing in males (𝑃 = 0.024). Exposure to a
45% fat diet throughout life also increased terminal body
weight compared with exposure in utero, during nursing, and
both in utero and during nursing, in both females and males
(𝑃 < 0.001 for all comparisons). The terminal body weight at
23 weeks was not significantly different between mice given a
45% fat diet as adults or throughout life in either gender.
Thus, the effects of an early exposure to a 45% fat diet
observed during the in utero and nursing periods, or only
during nursing, on terminal bodyweight at age 11 weeks, were
no longer present when the wild-type mice had reached the
age of 23 weeks.
3.12. Terminal BMI inMin/+MiceOffspring atWeek 11. When
terminating the Min/+ mice at 11 weeks of age, terminal
body weight and nasoanal length were recorded and BMI
was calculated as body weight divided by the square of
the nasoanal length (in g/cm2) (data not shown). The male
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Min/+ mice had significantly higher BMI at termination at
11 weeks compared with the females, and this was observed
in all experimental dietary groups (𝑃 < 0.001 for all
comparisons).Mice exposed to PhIP had a significantly lower
BMI compared with the untreated Min/+ mice (𝑃 < 0.001),
and this was seen in both mice given a 45% fat diet during
in utero and nursing, and throughout life (𝑃 = 0.009 and
𝑃 < 0.001, resp.), consistent with the other body weight
results (AUC for body weight development and body weight
at a specific time point).
None of the exposures to a 45% fat diet early in life; in
utero, during nursing, or both in utero and during nursing,
increased BMI compared with the negative control mice
given a 10% fat diet throughout life, in either gender.The same
results were found with exposure to a 45% fat diet as adults.
The BMI after a 45% fat diet as adults was not significantly
different from after a 45% fat diet in utero, during nursing,
or during both in utero and nursing. A 45% fat diet given
throughout life increased BMI compared with the negative
control group, and the mice given a 45% fat diet in utero,
in both genders separately (𝑃 < 0.001 and 𝑃 = 0.021 in
females, respectively, and 𝑃 = 0.013 and 𝑃 = 0.032, in males,
resp.). A 45% fat diet given throughout life also increasedBMI
compared with a 45% fat diet in utero and during nursing in
females (𝑃 < 0.001), and comparedwith a 45% fat diet during
nursing (𝑃 = 0.048) and compared with as adults (𝑃 = 0.011)
in males.
As opposed to body weight development as AUC from
day 3-4 to week 11 and terminal body weight at 11 weeks, the
end point terminal BMI at 11 weeks did not demonstrate early
life as a sensitive period for obesity from exposure to a high
fat diet in theMin/+mice.
3.13. Terminal BMI in Wild-Type Mice Offspring at Week 23.
The wild-type mice were terminated at week 23, and their
BMI values were calculated (data not shown).Themale wild-
type mice had significantly higher BMI at termination at 23
weeks compared with the females, and this was observed in
all dietary groups (𝑃 < 0.001 for all comparisons). At this
time point, there was no longer any significant difference in
BMI between mice exposed to PhIP or left untreated.
As found for Min/+ mice at 11 weeks, none of the
exposures of wild-type mice to a 45% fat diet early in life; in
utero, during nursing, or both in utero and during nursing,
increased BMI compared with in the negative control mice
given a 10% fat diet throughout life, in either gender. A 45% fat
diet as adults increased the BMI compared with the negative
control group (𝑃 < 0.001, for both genders), and compared
with exposure to a 45% fat diet given in utero (𝑃 = 0.014
and 𝑃 = 0.003) and both in utero and during nursing (𝑃 =
0.042 and 𝑃 = 0.040), in females and males, respectively,
and compared with a 45% fat diet given during nursing in
females (𝑃 = 0.047). A 45% fat diet given throughout life
increased BMI compared with the negative control mice, the
mice given a 45% fat diet in utero, during nursing, and both
in utero and during nursing, in both genders (𝑃 < 0.001
for all comparisons). The terminal BMI at 23 weeks was not
significantly difference between exposure to a 45% fat diet as
adults or throughout life.
Within the PhIP-exposed Min/+ mice, there was no
significant difference in terminal BMI between the exposure
to a 45% fat diet during the in utero and nursing period
compared with throughout life, either in females or males.
As was found for Min/+ mice at 11 weeks of age, the end
point terminal BMI at 23 weeks did no longer demonstrate
the sensitive period for obesity early in life from exposure to
a high fat diet in the wild-type mice.
3.14. Blood Glucose Levels. To test the hypothesis that obesity
may affect intestinal tumorigenesis by disturbing the blood
glucose regulation, blood glucose levels (nonfasted) were
measured in all mice. This was done at weeks 6 and 11 in
the Min/+ mice (Figure 7(a)), and at weeks 6 and 23 in the
wild-typemice (Figure 7(b)).When compared at 6 weeks, the
Min/+mice had higher levels of blood glucose than the wild-
type mice (𝑃 < 0.001), which was also found in our previous
experiments (see [33], Ngo et al., 2014; unpublished results).
The blood glucose levels were significantly higher in male
compared with female Min/+ mice, at both 6 and 11 weeks,
and in wild-type mice, at both 6 and 23 weeks, and in mice
treated with PhIP or not (𝑃 < 0.001 all comparisons). It was
also seen in all dietary groups for both time points together
(𝑃 < 0.001 for all comparisons).The blood glucose results are
presented for females and males separately (Figure 7).
The blood glucose levels measured at week 11 was signif-
icantly higher than at week 6, for females (𝑃 < 0.001) and
for males (𝑃 < 0.001), for PhIP-treated (𝑃 < 0.001) and
for untreated (𝑃 = 0.018) Min/+ mice. Blood glucose levels
measured at week 23 were significantly higher than at week
6 for wild-type females (𝑃 < 0.001), whereas for males, the
levels were higher at week 6 than week 23 (𝑃 = 0.036). Based
on all values from Min/+ mice at 6 and 11 weeks, the PhIP-
treated mice had higher blood glucose levels than mice not
treated with PhIP (𝑃 = 0.004), which was also observed in a
previous experiment (Ngo et al., 2014; unpublished results),
whereas this effect of PhIP was not significant for the wild-
type mice at weeks 6 and 23.
Exposure to a 45% fat diet only in utero, during nursing,
or both in utero and during nursing, did not significantly
increase blood glucose levels compared with the negative
control group given a 10% fat diet throughout life, neither in
Min/+mice or wild-type mice at any time point.
Based on both genders at 6 and 11 weeks, a 45% fat diet
given in adult life significantly increased the blood glucose
levels compared with the control diet (𝑃 = 0.038) and
exposure to a 45% fat diet during nursing (𝑃 = 0.009), but
not compared with exposure to a 45% fat diet in utero, or
both in utero andduring nursing, in theMin/+mice. Based on
both genders at 6 and 23 weeks, a 45% fat diet given in adult
life significantly increased the blood glucose levels compared
with the control diet (𝑃 = 0.006), exposure to a 45% fat diet
in utero (𝑃 < 0.001) and during nursing (𝑃 = 0.033), but not
compared with exposure to a 45% fat diet both in utero and
during nursing, in the wild-type mice. Based on both 6 and
23 weeks, a 45% fat diet given in adult life to female wild-type
mice separately significantly increased the blood glucose level
compared with the control diet (𝑃 = 0.030), exposure to a
45% fat diet in utero (𝑃 < 0.001), during nursing (𝑃 = 0.019),
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Figure 7: Nonfasted blood glucose levels (mmol/L, mean ± SD) for (a)Min/+ mice; females at 6 and 11 weeks and males at 6 and 11 weeks,
(b) wild-type mice; females at 6 and 23 weeks and males at 6 and 23 weeks, shown for both genotypes with columns in white, light grey, dark
grey and black color, respectively. P = PhIP. The experimental groups are as explained in the legend to Figure 1. 𝑛 = 9–46.
and also compared with exposure to a 45% fat diet both in
utero and during nursing (𝑃 = 0.018). Inmale wild-typemice
separately, there were no statistically significant effects of a
45% fat diet given in adult life.
Based on both genders at 6 and 11 weeks, a 45% fat
diet given throughout life significantly increased the blood
glucose levels compared with the negative control group (𝑃 <
0.001), the group exposed to the 45% fat diet in utero (𝑃 =
0.001), and during nursing (𝑃 < 0.001), but the differences
were not statistically significant compared with exposure to a
45% fat diet both in utero and during nursing, or as adults, in
the Min/+ mice. Based on both genders at 6 and 23 weeks,
in the wild-type mice a 45% fat diet given throughout life
significantly increased the blood glucose level compared with
the group exposed to the 45% fat diet in utero (𝑃 < 0.001),
but the differences were not statistically significant compared
with the negative control group, exposure to a 45% fat diet
during nursing, both in utero andduring nursing, or as adults.
Also based on both 6 and 11 weeks, in female wild-type mice
separately a 45% fat diet given throughout life significantly
increased the blood glucose levels compared with the group
exposed to the 45% fat diet in utero (𝑃 = 0.001), whereas the
comparisonswith the other groups did not reach significance.
Inmale wild-typemice separately, none of the various dietary
groups were significantly different. At 6 weeks separately,
none of the comparisons with the 45% fat dietary groups
reached significance compared with the control group, and
at 11 weeks separately, the only significant difference was
between the 45% fat diet throughout life compared with the
control group (𝑃 = 0.031).
A shorter exposure to a 45% fat diet early in life, that
is, in utero, during nursing, or both in utero and during
nursing, was apparently not able to affect the blood glucose
levels, whereas a longer exposure to a 45% fat diet as
adults or throughout life did increase the blood glucose
levels. However, exposure to a 45% diet as adults, and not
throughout life, increased blood glucose levels significantly
more than exposure both in utero and during nursing only in
the subgroup of female wild-type mice evaluated at 6 and 23
weeks (𝑃 = 0.018).
3.15. Glucose Tolerance Test (GTT). To get a clearer picture
of the effect on blood glucose regulation by the various
dietary combinations, GTT was performed at 10 weeks on a
subset of mice from each treatment group in a fasted state. A
larger area under the curve (AUC) in the glucose tolerance
test indicates that the mice have reduced ability to clear the
injected glucose from the blood. As for the nonfasted blood
glucose levels, significantly larger AUC was found in the
Min/+mice (Figures 8(a) and 8(b)) compared with the wild-
type mice (Figures 8(c) and 6(d)) (𝑃 < 0.001). And likewise,
males had significantly higher AUC compared with females
(𝑃 < 0.001), which is especially noticeable in the wild-type
mice (Figures 8(c) and 6(d)).
Blood glucose AUC was higher in PhIP-exposed mice
compared with mice not given PhIP after exposure to a 45%
fat diet throughout life (𝑃 < 0.001), but not after exposure to
a 45% fat diet in utero and during nursing (Figure 8).
The early exposure to a 45% diet in utero, during nursing,
or during both in utero and nursing, did not differ from the
control group given a 10% diet throughout life (Figure 8).
The mice in the groups exposed to a 45% fat diet as adults
or throughout life had significantly higher AUC than the
negative control group (𝑃 < 0.001 for both comparisons), and
the mice exposed to a 45% fat diet either during adult life or
throughout life also had significantly higher AUC compared
with all the other treatment groups, including the group given
a 45% fat diet both in utero and during nursing (𝑃 = 0.002 or
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Figure 8: Mean fasted blood glucose levels at age 10 weeks as area under the curve (AUC) (arbitrary units) in the glucose tolerance test in
(a) female and (b) male Min/+ mice, and in (c) female and (d) male wild-type mice. The symbols for the untreated mice of both genders
are: 10+10+10 (e), 45+10+10 (△), 10+45+10 (󳶚), 45+45+10 (◻), 10+10+45 (◊), and 45+45+45 (open hexagon), and the symbols for the PhIP-
treatedmice are in grey color; 45+45+10 PhIP (I) and 45+45+45 PhIP (△).The experimental groups are as explained in the legend to Figure 1.
𝑛 = 9–16.
𝑃 < 0.001 for all comparisons) (Figure 8). The two dietary
groups exposed to a 45% fat diet either during adult life or
throughout life did not have significantly different AUC.
These GTT results essentially confirmed the results
obtained by measuring blood glucose in a nonfasted state.
According to WHO [35], diagnostic criteria for humans
with impaired glucose tolerance (IGT) are 7.8–11.1mmol/L of
glucose measured 2 h after an oral dose of 75 gram glucose,
and levels above 11.1mmol/L confirm diabetes. Regarding
these levels also relevant for mice, we found IGT at the
2 h time point in the GTT in 8% and 23% (10+10+10),
5% and 69% (45+10+10), 0% and 68% (10+45+10), 27%
and 60% (45+45+10), 13% and 82% (10+10+45), 23% and
70% (45+45+45), 10% and 50% (45+45+10 PhIP), and 32%
and 92% (45+45+45 PhIP) of the female and male mice,
respectively (treatment groups in parentheses). A diabetic
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level of glucose at the 2 h time point in the GTT was found
in 0% and 0%, 0% and 7%, 0% and 5%, 5% and 5%, 0%
and 27%, 0% and 22%, 0% and 0%, and 5% and 25% of the
female andmale mice in the same treatment groups as above,
respectively.
3.16. Small Intestinal Tumors. All mice had small intestinal
tumors (adenomas), independent of dietary or carcinogenic
exposures, confirming 100% incidence of small intestinal
tumors as is commonly found in theMin/+mice [25–27, 33].
The number of small intestinal tumors was not significantly
different between the genders, thus the data for males and
females are presented together (Figure 9). Although slightly
increased, exposure to the 45% fat diet only in utero did not
significantly increase the number of small intestinal tumors
comparedwith the negative control group given a 10% fat diet
throughout life. Exposure to a 45% fat diet only during the
nursing periodwas significantly increased comparedwith the
negative control group (𝑃 < 0.05). However, exposure to a
45% fat diet both in utero and during nursing, significantly
increased the number of small intestinal tumors further,
compared with the negative control group (𝑃 < 0.05), and
compared with a 45% diet only in utero (𝑃 < 0.05), but
not compared with only during nursing. Thus the effect of
a 45% fat diet during the nursing period is more efficient in
increasing the tumor number than the exposure in utero.
Both exposure to a 45% fat diet in adult life or throughout
life gave a significant increase in small intestinal tumors
compared with the negative control group, the group given
a 45% fat diet in utero, and the group given a 45% fat diet
only during nursing (𝑃 < 0.05 for all comparisons). However,
exposure to a 45% fat diet in adult life or throughout life
did not significantly increase the number of small intestinal
tumors compared with the early exposure during both the in
utero and nursing periods, showing the importance of early
life exposure for intestinal tumor development by a high fat
diet. Unexpectedly, the exposure to a 45% fat diet throughout
life did not increase the number of small intestinal tumors
compared with this exposure only during adult life.
To compare the effects of a 45% fat diet on spontaneous
tumorigenesis with the effect on carcinogen-induced muta-
tion in or loss of the remaining inherited wild-type Apc
allele, two of the experimental groups were treated with the
foodmutagen and carcinogen PhIP.These groups were either
exposed to a 45% fat diet both in utero and during nursing
or a 45% fat diet throughout life. There were no gender
differences in the PhIP-treated groups or the control groups
without PhIP, and thus the data for males and females are
presented together (Figure 9). Both of the dietary groups
treated with PhIP showed significantly higher number of
small intestinal tumors compared with the untreated groups
receiving the same diets (𝑃 < 0.001 for both comparisons).
Hence, PhIP treatment increased intestinal tumorigenesis
above the spontaneous level of tumors in theMin/+mice, as
shown previously [25–27, 33].
Inmice treatedwith PhIP, a 45% fat diet given throughout
life gave a significantly higher number of small intestinal
tumors compared with exposure to a 45% fat diet during
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Figure 9: The number of small intestinal tumors for pooled male
and female Min/+ mice (mean ± SD). Two separate experimental
groups receiving a 45% fat diet during in utero and nursing
period or throughout life were injected with PhIP (marked P). The
experimental groups are as explained in the legend to Figure 1.
𝑛 = 44–65. aSignificantly different from the negative control group
given a 10% fat diet throughout life. bSignificantly different from the
group given a 45% fat diet throughout life. cSignificantly different
from the group given a 45% fat diet in utero and during nursing.
dSignificantly different with PhIP compared with no PhIP exposure
in the groups given a 45% fat diet during in utero and nursing
period. eSignificantly different with PhIP compared with no PhIP
exposure in the groups given a 45% fat diet throughout life. n.s. =
not significantly different.
in utero and nursing (𝑃 < 0.001), whereas this effect of diet
was not seen in the mice not treated with PhIP.
Small intestinal tumors from mice not treated with PhIP
had diameters of 0.2–3.6mm, whereas the tumor diame-
ters from PhIP-treated mice were 0.2–4.5mm. The males
appeared to have larger tumors than the females (𝑃 = 0.047
for all mice), however, the difference was not statistically
significant in most of the treatment groups, and the direction
of this difference was not consistent since in some groups
females had larger tumors than males.Therefore, the data are
evaluated statistically for females and males together (data
not shown).
In the mice exposed to a 45% fat diet in utero or
during nursing, the differences in tumor diameter were not
significantly different compared with the negative control
group given a 10% fat diet. In the mice receiving a 45% fat
diet during both the in utero and nursing periods, the tumors
were larger than in the control group (𝑃 = 0.035), indicating a
possible effect on tumor growth from this early exposure to a
45% fat diet.The 45% fat diet during both in utero and nursing
periods also gave significantly larger tumors compared with
all the other groups receiving a 45% fat diet for various
periods, including a 45% fat diet as adults and throughout life
(𝑃 < 0.001 for all comparisons). In the mice receiving a 45%
fat diet during adult life or throughout life, the tumors were
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Figure 10:The net effect on tumor size of (a) a 45% fat diet, and (b) of PhIP exposure. (a)The size distribution of small intestinal tumors from
untreated pooled female and male Min/+ mice exposed to a 45% fat diet for various periods is calculated by subtracting the mean number
of tumors in the mice exposed to a 10% fat diet throughout life from the mean number of tumors in the treatment groups receiving a 45%
fat diet for various periods for each tumor size class. (b) The size distribution of small intestinal tumors from pooled female and maleMin/+
mice exposed to PhIP is calculated by subtracting the mean number of spontaneous tumors in the mice not exposed to PhIP from the mean
number of tumors formed in PhIP-treated mice for each tumor size class. The intervals between the tumor size classes are 0.25mm. The
symbols for the experimental groups are as follows: in (a) 10+10+10 (I), 45+10+10 (◊), 10+45+10 (◻), 45+45+10 (e), 10+10+45 (X) 45+45+45
(◼), and in (b) the dietary groups without PhIP exposure; 45+45+10 (I), 45+45+45 (◻), and the same PhIP-exposed dietary groups with (e)
or (◼), respectively. The experimental groups are as explained in the legend to Figure 1. 𝑛 = 44–65.
smaller compared with in the negative controlmice (𝑃 < 0.05
for both comparisons), possibly indicating formation of new
tumors.The exposure to a 45% fat diet as adults or throughout
life gave significantly smaller tumors than in all the other
groups exposed to a 45% fat (𝑃 < 0.05 for all comparisons).
The exposure to a 45% fat diet throughout life did not affect
the tumor size differently from a 45% fat diet only as adults.
To better illustrate the variations in size of the small
intestinal tumors between the dietary groups, curves are
shown of the size distribution of tumors (Figure 10(a)),
calculated by subtracting the number of tumors in mice
exposed to a 10% fat diet throughout life from the number
of tumors in the other treatment groups receiving a 45% fat
diet for various periods for the different size classes of tumors.
It can be seen that the curve for exposure to a 45% fat diet
both in utero and during nursing is higher than the control
group and all other groups to the right, indicating more of
the larger tumors, whereas the other treatment groups have
curves below the control group for the larger tumor sizes,
indicating fewer larger tumors.
PhIP increased the size of the small intestinal tumors
compared with the same dietary groups without PhIP (data
not shown), both when exposed to a 45% fat diet in utero and
during nursing (𝑃 < 0.05) and when exposed throughout
life (𝑃 < 0.05). The PhIP-exposed group given a 45% fat
diet throughout life had larger tumors than the PhIP-exposed
group given a 45% fat diet in utero and during nursing (𝑃 <
0.05).
The size of the PhIP-induced tumors was illustrated by
curves of size distributions of PhIP-induced tumor popula-
tions, which were calculated by subtracting the number of
tumors in the corresponding dietary group not exposed to
PhIP from the number of tumors in the PhIP-treated groups
for the difference tumor size classes (Figure 10(b)). It can
be seen that the curves for the PhIP-exposed groups are to
the right of the curves for the corresponding dietary groups
not exposed to PhIP, illustrating larger tumors after PhIP
exposure.
3.17. Colonic Tumors. Not all of the mice had colonic tumors,
regardless of treatment, consistent with results found in
our previous experiments with Min/+ mice [25–27, 33, 34].
There was a higher incidence of colonic tumors in males
compared with females in the dietary groups given a 45% fat
diet only as adults (𝑃 = 0.031) and in PhIP-treated mice
after exposure during in utero and nursing (𝑃 = 0.030).
The only significant difference between the various dietary
combinations was a higher incidence of colonic tumors in the
female mice exposed to a 45% fat diet only in utero versus
only as adults (𝑃 = 0.038). A higher incidence of colonic
tumors was observed with PhIP in the group given a 45% fat
diet throughout life, in females separately (𝑃 = 0.016) and
in both genders combined (𝑃 = 0.018), compared with no
PhIP-treatment.
The number of colonic tumors was significantly higher in
males compared with females for all mice (𝑃 < 0.001), and in
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the treatment groups exposed to a 45% fat diet in utero and
during nursing (𝑃 = 0.023) and throughout life (𝑃 = 0.035),
hence the data are evaluated separately for females and males
(data not shown). Probably because of the very low number
of colonic tumors, statistical significance was not reached for
any of the differences between the dietary groups. However,
except for the comparison with a 45% fat diet in utero in
females, the number of colonic tumors after the 45% fat diet
in utero and during nursing was higher than in all the other
groups exposed to a 45% fat diet for various periods and
not treated with PhIP, in both females and males (data not
shown). PhIP significantly increased the number of colonic
tumors, in both the dietary group given a 45% fat diet in
utero and during nursing (𝑃 = 0.006) and throughout life
(𝑃 = 0.008).
Colonic tumors had diameters of 1.0–5.4mm in mice
from the dietary groups not exposed to PhIP, while the diam-
eter in the PhIP-treated groups ranged from 0.9–6.0mm.
There were no significant differences between the genders or
between the various dietary groups in colonic tumor size, and
there was no statistically significant effect of PhIP on colonic
tumor diameter (data not shown).
3.18. Localization of Tumors along the Small Intestine and
Colon. The majority of tumors were localized in the distal
two-thirds (in the middle and distal parts) of the small
intestine in the mice that were exposed to a 10% fat diet
throughout life, a 45% fat diet in utero, during nursing, or
during both in utero and nursing (Figure 11), as has usually
been found in our previous experimentswithMin/+mice [26,
27, 33, 34]. The mice that were given a 45% fat diet as adults
or throughout life had additional tumors in the proximal part
of the small intestine (Figure 11). The PhIP-treated mice had
most of the tumors localized in the distal two-thirds of the
small intestine and also quite high numbers in the proximal
part of the small intestine.This unusual additional increase in
tumors proximally in the small intestine was also observed in
a previous experiment with genetically-induced obese mice,
that is, inMin/+mice crossedwith ob/obmice,who gets obese
when homozygous mutated. Also in the previous experiment
as in the present study, the tumor number was increased
further in this area of the small intestine when the mice
were given a 45% fat diet (another brand in the previous
experiment than in the present experiment) (Ngo et al., 2014;
unpublished results).
The few colonic tumors present were localized mainly in
the middle to distal parts of the colon (Figure 11), as seen in
previous experiments withMin/+mice [26, 27, 33, 34].
3.19. Absolute and Relative Liver and Spleen Weights. To
examine if the obesogenic treatment in various periods of
life could affect organ weights, in addition to body weight,
the absolute and relative weights of liver and spleen were
measured at termination of the Min/+ mice at 11 weeks of
age, and of the wild-type mice at 23 weeks of age. In the
Min/+ mice (Table 1), the males had higher absolute liver
weight than the females, based on allmice, and in each dietary
treatment group separately (𝑃 < 0.001 for all comparisons).
The only significant differences in absolute liver weight found
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Figure 11: Localization of tumors along the small intestine and colon
for pooled female and male Min/+ mice; 10+10+10 (I), 45+10+10
(e), 10+45+10 (△), 45+45+10 (󳵳), 10+10+45 (◊) and 45+45+45 (X),
and the PhIP-exposed groups; 45+45+10 (◻), and 45+45+45 (◼).
The tumor position is given as distance from the stomach measured
in cm. The experimental groups are as explained in the legend to
Figure 1. 𝑛 = 44–65.
between the dietary treatment groupswere that themalemice
given a 45% fat diet during both in utero and nursing periods
had significantly higher absolute liver weight than the mice
given a 45% fat diet only as adults (𝑃 = 0.007) or throughout
life (𝑃 = 0.018). In the Min/+ males, exposure to a 45% fat
diet in utero and during nursing without PhIP gave a higher
absolute liver weight than the same diet with PhIP exposure
(𝑃 = 0.023). None of these differences between the dietary
treatment groups were seen in females.
The relative liver weight in % was not significantly
different between the males and females. Compared with the
negative control group given a 10% fat diet throughout life,
none of the other dietary treatment groups differed in relative
liver weight either in female or male Min/+ mice. In the
males, exposure to a 45% fat diet only in utero, only during
nursing, or in utero and during nursing, gave a higher relative
liver weight than a 45% fat diet throughout life (𝑃 < 0.001,
𝑃 = 0.045 and 𝑃 < 0.001, resp.). Exposure to a 45% fat diet
throughout life with PhIP gave a higher relative liver weight
than the same diet without PhIP exposure in theMin/+males
(𝑃 < 0.001) and females (𝑃 = 0.005). None of the other
comparisons of relative liver weight between dietary groups
reached significance in the females.
The absolute spleen weight was not significantly different
between the Min/+ females and males. The male Min/+
mice given a 45% fat diet in utero and during nursing had
significantly higher absolute spleen weight compared with
the negative control mice given a 10% fat diet throughout
life (𝑃 = 0.003), mice given a 45% fat diet only in utero
(𝑃 < 0.001), mice given a 45% fat diet as adults (𝑃 = 0.004)
and mice given a 45% fat diet throughout life (𝑃 = 0.005). In
the Min/+ males, exposure to a 45% fat diet throughout life
with PhIP gave a higher absolute spleen weight than the same
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Table 1: Effects of exposure to a 45% fat diet during various periods of life on absolute liver weight (ALW), relative liver weight (RLW),
absolute spleen weight (ASW), and relative spleen weight (RSW) in female and male Min/+ mice terminated at 11 weeks of age (mean of
individual mice in the group ± SD).
Experimental group 𝑛 BW (g) ALW (g) RLW (%) ASW (g) RSW (%)
Min/+, females
10 + 10 + 10 22 19.4 ± 1.6 0.74 ± 0.18 3.81 ± 0.74 0.12 ± 0.03 0.65 ± 0.21
45 + 10 + 10 17 20.1 ± 1.8 0.82 ± 0.16 4.08 ± 0.58 0.12 ± 0.05 0.60 ± 0.22
10 + 45 + 10 27 21.4 ± 1.8 0.82 ± 0.11 3.84 ± 0.55 0.15 ± 0.09 0.69 ± 0.42
45 + 45 + 10 18 20.1 ± 1.7 0.82 ± 0.10 4.10 ± 0.46 0.17 ± 0.11 0.86 ± 0.60a,b
10 + 10 + 45 34 20.9 ± 2.6 0.75 ± 0.13 3.64 ± 0.52 0.12 ± 0.05 0.58 ± 0.22a
45 + 45 + 45 22 23.2 ± 2.6 0.84 ± 0.14 3.66 ± 0.47a 0.13 ± 0.05a 0.55 ± 0.22b,c
45 + 45 + 10 PhIP 22 20.6 ± 2.2 0.86 ± 0.10 4.23 ± 0.54 0.21 ± 0.11 1.00 ± 0.55
45 + 45 + 45 PhIP 15 19.5 ± 2.9 0.83 ± 0.14 4.35 ± 0.84a 0.23 ± 0.11a 1.23 ± 0.68c
Min/+, males
10 + 10 + 10 17 27.4 ± 2.6 1.10 ± 0.19 4.01 ± 0.55 0.12 ± 0.05a 0.45 ± 0.21a
45 + 10 + 10 29 27.8 ± 2.6 1.16 ± 0.16 4.16 ± 0.36a 0.13 ± 0.07b 0.46 ± 0.26b
10 + 45 + 10 30 28.3 ± 2.8 1.14 ± 0.21 3.99 ± 0.55b 0.16 ± 0.08 0.59 ± 0.31
45 + 45 + 10 19 28.8 ± 2.2 1.22 ± 0.21a,b,c 4.23 ± 0.67c 0.21 ± 0.13a,b,c,d 0.75 ± 0.47a,b,c,d
10 + 10 + 45 25 28.0 ± 3.2 1.05 ± 0.15a 3.78 ± 0.56 0.13 ± 0.06c 0.48 ± 0.20c
45 + 45 + 45 29 29.9 ± 3.2 1.07 ± 0.15b 3.58 ± 0.45a,b,c,d 0.14 ± 0.06d,e 0.47 ± 0.22d,e
45 + 45 + 10 PhIP 27 25.3 ± 3.0 1.09 ± 0.14c 4.34 ± 0.49 0.23 ± 0.11 0.94 ± 0.52
45 + 45 + 45 PhIP 29 26.5 ± 5.6 1.09 ± 0.20 4.20 ± 0.84d 0.26 ± 0.09e 1.00 ± 0.39e
Relative liver weight (RLW) (%) = absolute liver weight (ALW)/body weight (BW)× 100, relative spleen weight (RSW) (%) = absolute spleen weight (ASW)/BW
× 100. g = gram.
a–eDietary treatment groups within each gender with similar letters are significantly different.
diet without PhIP exposure (𝑃 < 0.001). This comparison
was also significant in females (𝑃 = 0.013), whereas none of
the other comparisons of absolute spleen weight between the
dietary groups reached significance in the females.
The relative spleen weight in % was significantly higher
in female than in male Min/+ mice, based on all mice (𝑃 =
0.002), but this gender difference did not reach significance
in any of the dietary treatment groups separately. TheMin/+
mice given a 45% fat diet in utero and during nursing
had borderline or significantly higher relative spleen weight
compared with the control male mice given a 10% fat diet
throughout life (𝑃 = 0.051), male mice given a 45% fat diet in
utero (𝑃 = 0.025), a 45% fat diet as adults (𝑃 = 0.049 in males
and 𝑃 = 0.031 in females), and a 45% fat diet throughout life
(𝑃 = 0.028 in both males and females). The relative spleen
weight inMin/+mice given a 45% fat diet throughout lifewith
PhIP was significantly higher than the same dietary group
without PhIP, in both females and males (𝑃 < 0.001 for both
comparisons).
Also in thewild-typemice (Table 2), themales had higher
absolute liver weight than the females, based on all mice
(𝑃 < 0.001), and in each dietary treatment group separately
(𝑃 < 0.001 in all treatment groups, except for the group
given a 45% fat diet only during nursing where 𝑃 = 0.019).
The only significant differences in absolute liver weight found
between the dietary treatment groups in the wild-type mice
were that the male mice given a 45% fat diet throughout life
had significantly higher absolute liver weight than the control
mice given a 10% fat diet throughout life (𝑃 = 0.028) and the
mice given a 45% fat diet only during nursing (𝑃 = 0.027),
whereas these differences were not seen in females. PhIP
treatment did not affect the absolute liver weight in the wild-
type mice.
The relative liver weight in %was also significantly higher
in males than in females, based on all mice (𝑃 < 0.001), and
also in the individual dietary treatment groups of mice given
a 45% fat diet in utero (𝑃 = 0.017), as adults (𝑃 = 0.024),
or throughout life (𝑃 < 0.001). No significant differences
were found in relative liver weight between any of the dietary
treatment groups in male wild-type mice. In females, the
relative liver weight was significantly higher in mice in the
negative control group given a 10% fat diet throughout life
(𝑃 < 0.001), a 45% fat diet in utero (𝑃 = 0.003), a 45% fat diet
during nursing (𝑃 < 0.001), or a 45% diet in utero and during
nursing (𝑃 < 0.001), compared with the mice given a 45%
diet throughout life. In females, the relative liver weight was
also significantly higher inmice in the negative control group
given a 10% fat diet throughout life (𝑃 < 0.030), a 45% fat
diet during nursing (𝑃 = 0.008), or a 45% fat diet in utero and
during nursing (𝑃 = 0.048), compared with the mice given a
45% diet as adults. PhIP treatment did not affect the relative
liver weight in wild-type mice.
There were no significant differences in absolute spleen
weight between the genders among the wild-type mice. The
only significant difference between the dietary treatment
groups was a higher absolute spleen weight in female wild-
type mice given a 45% fat diet during nursing compared with
as adults (𝑃 = 0.004), which was not seen in males. PhIP
treatment did not affect the absolute spleen weight in wild-
type mice.
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Table 2: Effects of exposure to a 45% fat diet during various periods of life on absolute liver weight (ALW), relative liver weight (RLW),
absolute spleen weight (ASW), and relative spleen weight (RSW) in female and male wild-type mice terminated at 23 weeks of age (mean of
individual mice in the group ± SD).
Experimental group n BW (g) ALW (g) RLW (%) ASW (g) RSW (%)
+/+, females
10 + 10 + 10 26 25.9 ± 3.3 1.03 ± 0.34 3.91 ± 0.87a,e 0.12 ± 0.03 0.45 ± 0.13a,b
45 + 10 + 10 24 26.8 ± 4.2 1.03 ± 0.32 3.79 ± 0.85b 0.11 ± 0.03 0.41 ± 0.12
10 + 45 + 10 21 28.0 ± 3.9 1.15 ± 0.38 4.04 ± 0.89c,f 0.14 ± 0.09a 0.50 ± 0.37c,d
45 + 45 + 10 31 27.6 ± 3.9 1.08 ± 0.35 3.84 ± 0.83d,g 0.11 ± 0.03 0.42 ± 0.14
10 + 10 + 45 26 31.3 ± 6.2 1.02 ± 0.22 3.27 ± 0.49e,f,g 0.10 ± 0.02a 0.33 ± 0.10a,c
45 + 45 + 45 31 34.3 ± 4.0 1.04 ± 0.23 3.02 ± 0.51a,b,c,d 0.11 ± 0.02 0.34 ± 0.09b,d
45 + 45 + 10 PhIP 21 27.0 ± 3.6 1.11 ± 0.34 4.06 ± 0.87 0.12 ± 0.03 0.43 ± 0.13
45 + 45 + 45 PhIP 21 33.9 ± 7.5 1.05 ± 0.32 3.09 ± 0.66 0.11 ± 0.02 0.34 ± 0.11
+/+, males
10 + 10 + 10 25 35.0 ± 5.1 1.43 ± 0.41a 4.02 ± 0.75 0.11 ± 0.02 0.34 ± 0.11
45 + 10 + 10 36 36.0 ± 4.3 1.54 ± 0.26 4.28 ± 0.53 0.11 ± 0.02 0.30 ± 0.07
10 + 45 + 10 24 37.2 ± 4.2 1.42 ± 0.24b 3.81 ± 0.47 0.11 ± 0.02 0.30 ± 0.07
45 + 45 + 10 27 36.4 ± 5.6 1.51 ± 0.37 4.18 ± 0.90 0.10 ± 0.03 0.29 ± 0.09
10 + 10 + 45 27 40.5 ± 7.5 1.54 ± 0.53 3.75 ± 0.83 0.10 ± 0.02 0.25 ± 0.07
45 + 45 + 45 46 42.9 ± 5.8 1.73 ± 0.59a,b 3.95 ± 0.98 0.12 ± 0.02 0.28 ± 0.08
45 + 45 + 10 PhIP 25 38.5 ± 4.1 1.49 ± 0.30 3.84 ± 0.47 0.12 ± 0.04 0.32 ± 0.15
45 + 45 + 45 PhIP 28 44.6 ± 5.0 1.70 ± 0.47 3.76 ± 0.74 0.11 ± 0.02 0.24 ± 0.05
Relative liver weight (RLW) (%) = absolute liver weight (ALW)/body weight (BW)× 100, relative spleen weight (RSW) (%) = absolute spleen weight (ASW)/BW
× 100. g = gram.
a–fDietary treatment groups within each gender with similar letters are significantly different.
The relative spleen weight in % was significantly higher
in female than in male wild-type mice also, based on all mice
(𝑃 < 0.001), and this difference reached significance in all of
the dietary treatment groups separately, except for the group
given a 45% fat diet throughout life (𝑃 values varied from
< 0.001 to 0.028). No significant differences were found in
relative spleen weight between any of the dietary treatment
groups in male mice. Female mice in the negative control
group given a 10% fat diet throughout life had significantly
higher relative spleen weight compared with the mice given a
45% fat diet as adults, and compared with mice given a 45%
fat diet throughout life (𝑃 = 0.020 for both comparisons).
Also female mice given a 45% fat diet only during nursing
had significantly higher relative spleen weight compared with
the mice given a 45% fat diet as adults, and compared with
mice given a 45% fat diet throughout life (𝑃 < 0.001 for
both comparisons). PhIP treatment did not affect the relative
spleen weight in wild-type mice.
3.20. Serum Leptin Levels. There were no significant differ-
ences in levels of the serum hormone leptin obtained at
termination between the genders of mice or between any of
the dietary treatment groups (Figure 12).The only significant
difference foundwas that thewild-typemice had significantly
higher levels of leptin than the Min/+ mice. This was found
based on all mice (𝑃 < 0.001), and in the dietary group of
mice given a 45% fat diet both in utero and during nursing
(𝑃 < 0.001).
4. Discussion
The intake of feed per gram body weight in the dams was
significantly lower for the 45% fat diet than the 10% fat diet
during the second and third week of pregnancy (Figure 2(a)).
This was most likely caused by a lower feed intake and/or
increased body weight (Figure 4) with the 45% diet, and not
by different number of pups per litter, since both dietary
groups of dams gave birth to similar mean number of pups
per litter.
Themice given a 45% fat diet either as adults (for 8 weeks)
or throughout life (for 11 weeks), with or without PhIP, had
significantly lower feed intake per gram body weight per
week than the other dietary groups receiving a 10% fat diet
throughout life (for 11 weeks or 23 weeks), or a 45% fat diet for
shorter time, that is, only in utero (for 3 weeks), only during
nursing (for 3 weeks) or during in utero and nursing (for 6
weeks), with or without PhIP (Figure 3). Apparently, there
is an adjustment of feed intake, that is, calorie intake, over
time, leading to lower intake of the 45% fat diet compared
with the 10% fat diet or the 45% fat diet for shorter time.
This difference in feed intake between long exposure versus
no/short exposure to a 45% fat diet varied with the individual
diets and in the individual weeks but reached approximately
20–30% from weeks 5-6 to week 11 in both Min/+ and wild-
type female and male mice, and in most of the weeks in both
female andmale wild-typemice at weeks 12 to 23.The 45% fat
diet has 4.73 kcal/g, whereas the 10% fat diet has 3.85 kcal/g,
that is, the 45% fat diet contains 22.9% more kcal per gram
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Figure 12: The concentration of leptin in serum at termination was
measured in bothMin/+ and wild-type (+/+) mice of both genders
from all the dietary groups except 10+10+45 (see explanation in the
legend to Figure 1), not treated with PhIP (𝑛 = 6). Females (white
columns), males (black columns).
diet. Therefore, it appears that the mice adjusted their intake
of feed to approximately the same level of kcal, and the effects
observed in this experiment are likely caused by the dietary
fat as such more than by just the excess calories.
The body weights of the dams during weeks 1 and 2 of
pregnancy were significantly higher for the dams on a 45%
fat diet compared with dams on a 10% fat diet, although the
differenceswere small, being 3.3% atweek 1 and 7.2% atweek 2
(Figure 4). At the end of the pregnancy, the difference was
only 2.0% and not significant. Since the dams had increased
bodyweight after the 45% fat diet, it is not possible to separate
the effect on the offspring in utero of increased body weight
(obesity) in the dams from the effects of the 45% fat diet as
such.
The 10% fat and 45% fat diets both have 20 kcal% protein
and the same content of vitamins and minerals. The 10% and
45% fat diets are matched on sucrose, that is, both contain
17% sucrose as percentage of the calories. However, there are
differences in other carbohydrates, that is, the 45% fat diet
contains less corn starch (291 kcal) and more maltodextrin
10 (a partially hydrolyzed form of corn starch, 400 kcal),
than the 10% fat diet (1808.8 kcal corn starch and 300 kcal
maltodextrin 10), in total 35 kcal% comes from carbohydrate
in the 45% fat diet compared with 70 kcal% in the 10% fat
diet. Regarding the content of fat, both diets have the same
kcal% from soybean oil (225 kcal), but the 45% fat diet has
almost 9 times the content of lard (1598 kcal) as in the 10% fat
diet (180 kcal), and in total 45 kcal% comes from fat compared
with 10 kcal%.
Since the mice apparently adjust their feed intake over
time to approximately the same percentage of calories,
the effects observed in this study may be caused by other
difference in the diets than calories, that is, by the content of
carbohydrates other than sucrose or by the lard (type of fat).
In human studies, various indicators of obesity, such
as BMI, waist circumference and waist-to-hip ratio, waist-
height-ratio or percentage of body fat, have been found to
be more or less strongly associated with study end points
[36]. In this work, we have evaluated obesity in three different
ways; as body weight development using AUC calculated for
a specified time period, as body weight at a specific age and
as terminal BMI.
When evaluated as AUC from age 3-4 days to 11 weeks,
there was an obesogenic effect of an early exposure to a
45% fat diet in utero and during nursing, or only during
nursing, showing that the intrauterine and nursing period
is a susceptible window of exposure to a high fat diet for
later development of obesity as adults (Figures 6(a)–6(d)).
However, this effect in AUC from day 3-4 to week 11 of
an early exposure to a 45% fat diet was no longer present
when evaluated as AUC for the age of 12 to 23 weeks in the
wild-type mice (Figures 6(e) and 6(f)), indicating that this
effect was transient. Similarly, the observed effects of an early
exposure to a 45% fat diet during in utero and nursing, or only
during nursing, on bodyweight at age 11 weekswere no longer
present when the wild-type mice had reached the age of 23
weeks. As opposed to bodyweight development as AUC from
day 3-4 to week 11 and body weight at 11 weeks, the end point
terminal BMI at 11 weeks did not demonstrate the sensitive
period for obesity early in life from exposure to a 45% fat diet
in theMin/+mice. Likewise, the end point terminal BMI at 23
weeks did not demonstrate in thewild-typemice the sensitive
period for obesity early in life from exposure to a 45% fat
diet. So for this end point, BMI was not as sensitive as body
weight at a specific age, and even less sensitive, comparedwith
AUC for body weight development. AUC, which integrates
the changes in body weight over a longer period of time, was
the best end point in this experiment. BMI was also found
to be the least sensitive and specific of several obesity-related
predictors of metabolic syndrome in a human population
[36].
In addition to affecting the body weight of the mice, the
early exposure to a 45% fat diet during both in utero and
nursing periods increased the organ weights compared with
the much longer exposure to a 45% fat diet later in life, that
is, as adults or throughout life. This was observed for the
relative liver weight compared with a 45% fat diet throughout
life in male Min/+ mice (Table 1), and compared with a 45%
fat diet as adults or throughout life in female wild-type mice
(Table 2). Also the relative spleen weight after exposure to
a 45% fat diet during both in utero and nursing periods
was increased compared with a 45% fat diet as adults or
throughout life in both female andmaleMin/+mice (Table 1).
The absolute liver weight and the absolute spleen weight were
also increased by the exposure to a 45% fat diet during both
in utero and nursing periods compared with a 45% fat diet as
adults or throughout life in maleMin/+mice (Table 1).
Maternal obesity and developmental programming of
metabolic disorders in the offspring have been studied exten-
sively in animal models [37–40]. Animal studies indicate that
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both the fetal period and the postnatal period may be critical
windows for development, and hence, alterations in the
nutrition during these periods could induce metabolic pro-
gramming effects, which may be manifested as pathological
conditions later in life. Several physiological and metabolic
mechanisms are not fully matured at birth and continue
maturation in the immediate postnatal period, for example,
neurons and pancreatic islets continue to develop after birth
in rodents [41]. Many studies have exposed female animals
for a high fat diet early in life; during pregnancy or during
lactation, or during both periods, and found long-term
consequences of metabolic and endocrine pathophysiology
in one or both genders of the offspring as adults, both in
mice [42–44] and rats [45–48]. Interestingly, prenatal stress
seems to have similar effects as a high fat diet for increased
susceptibility to diet-induced obesity in the offspring [47].
Relevant data also come from human studies. For instance,
it was shown that high pregnancy weight gain was associated
with increased body weight of the offspring in childhood,
and that this effect was only partially mediated through
higher birth weight [49]. However, this question is still
not resolved in humans, since in another study, maternal
overweight/obesity was associated with early deceleration of
growth, seen as less weight gain, less length growth and less
fat mass at three months of age [50]. A systematic review of
maternal and paternal body mass index and offspring obesity
concluded that there was only limited evidence to support the
fetal overnutrition hypothesis in humans [51].
However, we have compared the outcome of exposure
to a 45% fat diet among several specific periods of life. For
body weight measured as AUC from day 3-4 to week 11 and
as body weight at age 11 weeks, and for the number of small
intestinal tumors, exposure only in utero had less effect that
exposure during nursing, or during both the in utero and
nursing periods. The diameter of small intestinal tumors was
also increased after exposure during both the in utero and
nursing periods. These results point to exposure via the milk
during the nursing period as more important than exposure
in utero for these effects. Another study in mice found that
a high fat diet limited to the lactation period caused diet-
induced obesity in the male offspring [44]. Also, a study in
rats showed that maternal high fat diet during the nursing
period had greater influence on the offspring’s metabolic
phenotype and body weight than prenatal (in utero) high fat
diet [52]. For obvious reasons, studies in humans are not able
to compare obesogenic exposure in separated periods of life,
such as during pregnancy and the lactation period. However,
in a case-cohort study of Danish children, it was found that
infant weight and weight gain already during the first months
of life were associated with obesity in childhood [53]. They
did not observe any particular critical time period during
infancy related to the weight gain from 2 weeks to 9 months
of age; odds ratios increased from 1.27 associated with an
increase of 1 weight-tertile from age 2 weeks to 1 month, and
to 1.54 from 2 to 3 months of age, thereafter the odds ratio
were stable until 9 months of age.
Our data stress the importance of early exposure to
obesogenic conditions compared with the same exposure
later in life, that is, as adults. For instance, the exposure to a
45% fat diet as adults did not increase body weight as AUC
from day 3-4 to week 11 compared with the control group
or any of the other exposure groups, whereas the exposure
to a 45% fat diet during nursing actually gave a significantly
higher AUC than exposure as adults in Min/+ male mice
(𝑃 = 0.011). Also for body weight of Min/+ and wild-type
mice at 11 weeks of age and terminal BMI for Min/+ mice
at 11 weeks of age, the effects of a 45% fat diet as adults did
not increase the values compared with exposure in utero,
during nursing, or during both in utero and nursing. One
could speculate if this effect was only due to differences in
length of exposure to a 45% fat diet, rather that exposure
in a particular period. However, this is not the case, since
exposure as adults is from weaning at age 3 weeks until age 11
weeks forMin/+mice, and from weaning at age 3 weeks until
age 23 weeks for wild-type mice, that is, in 8 and 20 weeks,
respectively. Exposure throughout life is from conception to
termination at 11 weeks forMin/+mice, and from conception
to termination at 23 weeks for wild-type mice, that is, 14
and 26 weeks, respectively. In comparison, the exposure to
a 45% fat diet in utero was for 3 weeks, the exposure during
nursing was for 3 weeks, and the exposure both in utero and
during nursing was then for 6 weeks, all much shorter than
the exposures to a 45% fat diet as adults and throughout life.
As opposed to the situation at 11 weeks, when comparing
body weight after exposure as adults with the earlier exposure
periods using AUC for body weight, body weight at 23
weeks or terminal BMI at 23 weeks in wild-type mice, the
adult exposures increase these parameters compared with
exposure in utero, during nursing, or both in utero and during
nursing, indicating that the importance of early exposure has
disappeared some time between 11 and 23 weeks of age. This
early exposure effect seen at 11 weeks, but not at 23 weeks, is
not caused by a difference betweenMin/+mice (terminated at
11 weeks) and wild-type mice (terminated at 23 weeks), since
both genotypes are implicated in these results at 11 weeks.
Maternal obesity may have consequences for production
and secretion of adipokines from the adipose tissues, such as
leptin. Leptin has been shown to be important for placental
function and maternal-fetal exchange processes regulating
growth and development, and in later stages of pregnancy
central leptin resistance occurs to allow increased nutrient
availability for the fetus [54]. Disruption of signaling capacity
of leptin associated with obesity is a potential risk factor lead-
ing to pregnancy complications as a result of fuel partitioning
in utero.
The only significant difference in serum leptin levels
measured at termination in this study was that the Min/+
mice had significantly lower levels of leptin than the wild-
type mice (Figure 12). At the same time, the body weight as
AUC from day 3-4 to week 11 (Figure 6) and the body weight
at week 11 were lower in Min/+ mice (Figure 5(a)) than in
wild-type mice (Figure 5(b)). Therefore, in this experiment
higher leptin levels were associated with increased body
weight (in wild-type mice), whereas lower levels of leptin
were associated with lower body weight (in Min/+ mice).
The wild-type mice results are more similar to the situation
in humans where obesity is associated with elevated levels
of leptin, representing a form of leptin resistance [55, 56],
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as opposed to the ob/obmousemodel where the lack of leptin
is associated with extreme obesity (see [30, 31], Ngo et al.,
2014; unpublished results).
Alterations in nutrition, such as feeding a high fat diet,
during critical periods of prenatal or postnatal development
may induce permanent changes in the responsiveness of
hypothalamic neurons to hormone signals regulating energy
homeostasis and feeding, leading to increase in food intake,
preference for fatty food, hyperlipidemia and higher body
weight, thereby affecting the chances of becoming obese
later in life [57–59]. Leptin and insulin are likely hormonal
mediators for the environmental nutrient sensing system that
controls feeding. Data implicate a postnatal leptin surge to be
an important trophic factor for the development of hypotha-
lamic feeding circuits and is critical for normal energy
balance and hypothalamic regulation of feeding later in life
[59]. Data also show that changes in insulin levels, specifically
hyperinsulinemia, during pregnancy could induce alterations
in hypothalamic organization that may affect metabolism of
the offspring later in life [59].
The Min/+ mice (Figure 7(a)) had significantly higher
nonfasted blood glucose levels than the wild-type mice
(Figure 7(b)) at 6 weeks (𝑃 < 0.001), and also a larger
AUC in GTT after being fasted (Figure 8). Since the feed
intake in this experiment was recorded per litter, which
consisted of bothMin/+ and wild-type mice, it is not known
whether there was a difference in feed intake betweenMin/+
and wild-type mice that could explain their differences in
blood glucose levels. However, this is not likely, since our
previous experiment found similar feed intake in Min/+
and wild-type mice measured in metabolic cages (Ngo et
al., 2014; unpublished results). Also, the body weight was
lower inMin/+mice than in wild-type mice for body weight
evaluated as AUC from day 3-4 to 11 weeks (Figure 6) and as
body weight at 11 weeks (Figure 5). However, an alternative
explanation for the difference in blood glucose levels may
be that APC is involved in regulation of epithelial glucose
transport in the intestines, since Min/+ mice had increased
activity of the electrogenic glucose carrier (SGLT1) compared
with wild-type mice [60]. APC is a component of the Wnt
signaling pathway [19, 20]. Other intriguing possibilities of
a relationship between APC and blood glucose levels come
from data showing that the Wnt signaling pathway, which
is as an important modulator of adipocyte differentiation
[61, 62], also influences endocrine pancreas development
and modulates mature 𝛽-cell functions, including insulin
secretion, survival and proliferation, and thereby may be
involved in the pathogenesis of diabetes [63]. Components
of the Wnt signaling pathway may also be involved in
determining susceptibility to diet-induced obesity [64].
Based on all values from Min/+ mice at 6 and 11 weeks,
the PhIP-treated mice had higher blood glucose levels than
mice not treated with PhIP (𝑃 = 0.004) (Figure 7(a)), which
was also observed previously (Ngo et al., 2014; unpublished
results), whereas this effect of PhIP was not significant for
the wild-type mice at weeks 6 and 23 (Figure 7(b)). Blood
glucose AUC in GTT was also higher in PhIP-exposed mice
compared with mice not given PhIP after exposure to a 45%
fat diet throughout life (𝑃 < 0.001), but not after exposure to a
45% fat diet in utero and during nursing (Figure 8).Therefore,
at one or several conditions favoring intestinal tumorigenesis,
that is,Min/+mutation, exposure to the carcinogen PhIP and
a 45% fat diet, the blood glucose levels were increased.
Exposure to the 45% fat diet only in utero did not signif-
icantly increase the number of spontaneous small intestinal
tumors comparedwith the negative control group given a 10%
fat diet throughout life (Figure 9). Exposure to a 45% fat diet
only during the nursing period was significantly increased
compared with the negative control group (𝑃 < 0.05), and
exposure to a 45% fat diet during both the in utero and
nursing periods significantly increased the tumor numbers
further compared both with the negative control group (𝑃 <
0.05), and the 45% fat diet only in utero (𝑃 < 0.05), but
not compared with only during nursing. Thus, the effect of
a 45% fat diet during the nursing period is more efficient
in increasing the tumor number than the exposure in utero.
These data show a direct adverse effect on the offspring
as adults from obesogenic conditions early in life. Also, if
comparing the tumor results using litter instead of individual
mice as the statistical unit, the main findings are essentially
similar.The exceptions are that the tumor number after a 45%
fat diet only during nursingwas no longer significantly higher
compared with a 10% fat diet throughout life, and a 45% fat
diet throughout life was no longer significantly higher than a
45% fat diet in utero or only during nursing (data not shown).
Both exposures to a 45% fat diet in adult life or through-
out life gave a significant increase in small intestinal tumors
compared with the negative control group, the group given
a 45% fat diet in utero and the group given a 45% fat diet
only during nursing (𝑃 < 0.05 for all comparisons). Exposure
to a 45% fat diet in adult life or throughout life did not
significantly increase the number of small intestinal tumors
compared with the early exposure during both in utero and
nursing, indicating the importance of early life exposure for
intestinal tumor development by a high fat diet. However, it
is a discrepancy in these results, since it would be expected
that exposure to a 45% fat diet throughout the whole life
should give tumor numbers approaching the sum of tumor
numbers after exposure to a 45% fat diet in utero and during
nursing (i.e., early in life) and as adults (the rest of the life),
whereas the tumor numbers in these three groups were not
significantly different, that is, they were similar.
It is not known whether a 45% fat diet in these mice had
an effect on tumor initiation, by causing mutation or loss of
heterozygosity (LOH) in the remaining wild-type allele of the
Apc gene, or affected promotion, that is, the growth of already
initiated stem cells in the intestines, causing more tumors to
reach a size detectable in the microscope at termination, or
if both mechanisms were involved. These factors will affect
the final tumor numbers measured at a specific time point.
Lipotoxic free fatty acids from the 45% fat diet [65–67] and/or
the subsequent obesity [68] may cause oxidative stress and
accumulation of reactive oxygen species (ROS), which may
have led to subsequent DNA damage and tumor initiation in
the intestines.
Regarding exposure to a 45% fat diet early versus late in
life, the effects on body weight coincide well with the effects
on small intestinal tumor number, implicating an association
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between obesity and intestinal tumorigenesis. There was an
obesogenic effect of an early exposure to a 45% fat diet in utero
and during nursing, or only during nursing, when evaluated
as AUC from age 3-4 days to 11 weeks or as body weight
at 11 weeks, and there was significantly increased number of
tumors after early exposure to a 45% fat diet during nursing or
during both the in utero and nursing periods.The exposure to
a 45% fat diet as adults was not able to increase bodyweight as
AUC fromday 3-4 to 11 weeks, bodyweight at 11 weeks or BMI
at 11 weeks compared with the early exposure during both in
utero and nursing, and similarly, a 45% fat diet as adults was
not able to increase the tumor number compared with the
early exposure during both in utero and nursing.
Inmice treatedwith PhIP, a 45% fat diet given throughout
life gave a significantly higher number of small intestinal
tumors compared with exposure to a 45% fat diet during in
utero and nursing (𝑃 < 0.001), whereas this dietary effect
was not seen in the mice not treated with PhIP. In the PhIP-
exposedMin/+mice there were no differences in either AUC
from day 3-4 to 11 weeks, body weight at 11 weeks or terminal
BMI at 11 weeks between exposure to a 45% fat diet during
in utero and nursing, or throughout life. This is difficult
to interpret since PhIP itself decreased the body weight
evaluated with all three body weight parameters, probably
because of the increased tumor burden. Possibly, the weight-
decreasing effect of PhIP could have counteracted the weight-
increasing effect of the 45% fat diet, or the fat itself more
than the body weight affected the number of PhIP-induced
small intestinal tumors. In an earlier experiment, a 45% fat
diet during adult life did not increase the number of PhIP-
induced small intestinal tumors compared with exposure to a
10% fat diet inMin/+ × obmice (Ngo et al., 2014; unpublished
results).
The 45% fat diet during both in utero and nursing periods
also gave significantly larger tumors compared with the
negative control group and all the other groups receiving a
45% fat diet for various periods, including a 45% fat diet as
adults and throughout life (𝑃 < 0.001 for all comparisons),
indicating a possible effect on tumor growth from this early
exposure to a 45% fat diet (Figure 10(a)). The opposite was
seen with exposure to a 45% fat diet later in life.The exposure
to a 45% fat diet as adults or throughout life gave significantly
smaller tumors than in the negative control mice and all the
other groups exposed to a 45% fat diet early in life (𝑃 < 0.05
for all comparisons), possibly indicating formation of new
tumors. The exposure to a 45% fat diet throughout life did
not affect the tumor size differently from a 45% fat diet only
as adults.
ThePhIP-induced tumors were both increased in number
and significantly larger compared with the spontaneous
tumors in the small intestine (Figure 10(b)). Whether the
larger diameter of these tumors was due to an earlier
induction, a faster growth, or a combination of both events,
is not known.
The mice that were given a 45% fat diet as adults or
throughout life had additional tumors in the proximal part of
the small intestine, which was also seen after PhIP exposure
(Figure 11).This unusual increase in tumors proximally in the
small intestine, in addition to the more common distribution
in the middle and distal parts of the small intestine, was also
observed in a previous experiment with genetically-induced
obese mice, that is, in Min/+ mice crossed with ob mice,
who gets obese when homozygous mutated (Ngo et al., 2014;
unpublished results).
In the previous experiment, the number of proximal
tumors was especially high in the obese ob/ob mice and was
further increased with another brand of a 45% fat diet. The
reason for this phenomenon therefore seems to be associated
with genetical or diet-induced obesity. It could be speculated
whether it is caused by the increased secretion of bile acid
into this small intestinal area caused by the high fat diet, as
had been suggested to cause intestinal cancer [69].
In this experiment, blood glucose levels were measured
and GTTwas performed to study the hypothesis of disrupted
blood glucose regulation as a link between obesity and
intestinal tumorigenesis [28, 29]. However, based on both
end points a shorter exposure to a 45% fat diet early in life,
that is, in utero, during nursing, or both in utero and during
nursing, was apparently not able to affect the blood glucose
levels, whereas a longer exposure to a 45% fat diet as adults or
throughout life did increase blood glucose. Therefore, in this
experiment the exposure time to a 45% fat diet during the
early periods of life was too short to affect the glucose levels,
and the effects of the 45% fat diet and obesity on the intestinal
tumorigenesis worked through a mechanism independent of
blood glucose regulation.However, it should be noted that the
only significant difference between later and early exposure
was that exposure to a 45% diet as adults, and not throughout
life, increased blood glucose levels compared with exposure
both in utero and during nursing at 6 and 23 weeks in female
wild-type mice separately (𝑃 = 0.018).
It is suggested that prenatal genetic or environmen-
tal factors may disrupt early development and produce
long-term increased susceptibility of the offspring to new
metabolic challenges later in life, causing various pathological
conditions. However, in this study, we have shown that
the exposure to obesogenic conditions early in life directly
affected obesity in adults on a 10% fat diet without the
need for a challenge in the form of exposure to a 45% fat
diet also as adults. Similarly, the number of tumors formed
spontaneously because of the inherited mutation in Apc
was increases after early exposure to obesogenic conditions
without a second dietary challenge as adults.
There is growing interest also in the developmental
origins of cancer [70–72]. Also in this context, there are
proposed influences of adipokines, such as leptin and
adiponectin [73], and also insulin, on central mechanisms
of energy balance, causing irreversible changes in hypotha-
lamic neural interconnections leading to obesity and cancer.
Another possibility is epigenetic modifications of specific
genes, including tumor suppressor genes or oncogenes, and
their altered expression, leading to cancer development. Not
only a high fat diet, but other nutritional components may
impact on developmental origin of cancer, since it was
shown in rats that dietary protein type (soy protein isolate
versus casein) during pregnancy had different effects on
azoxymethane-induced colon tumor number and colon tis-
sue gene expression, as well as serum IGF-I and testosterone
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levels in the offspring as adults [74]. It has also been shown in
humans that body fatness at ages 5 and 10 years and higher
adult height were associated with increased risk of distal
adenoma, but not proximal or rectal adenoma, later in life,
independent of adult body weight [75].
Apparently, the effect on adult body weight of exposures
early in life disappeared sometime between 11 and 23 weeks
of age. In spite of this observation, it would still be interesting
to see if the effects on both body weight and intestinal
tumorigenesis were transferred to the next generations, and if
so, what would be the mechanisms for this transgenerational
transfer. Even if the effects should be transient, they are
present into reproductive age, and as such could affect the
subsequent offspring.
It may be that the worldwide epidemic of obesity and
subsequent risk of diabetes or metabolic syndrome and
other illnesses may not only be a result of our own lifestyle
of inadequate activity and poor diet as adults, but it may
also be propagated and increased earlier in life because
of unhealthy metabolic conditions in utero, that is, with
fetal overgrowth/adiposity or undergrowth, as well as by
obesogenic conditions during early childhood. Prevention,
rather than treatment, is of interest.
There seems to be an opportunity to potentially break the
cycle of obesity during pregnancy leading to obese children
[76], if managing to make obese women lose weight and
achieve a normal bodyweight/BMI prior to conception. It has
been shown that maternal obesity increased both maternal
and placental inflammation, but that this inflammation could
be reduced by an increase in N-3/N-6 fatty acid ratio, which
limited the adverse effects on the child of the developmental
programming caused by thematernal obesity [77].Therefore,
even if obese mothers are not able to lose weight before or
during pregnancy, improving their nutrition during preg-
nancy may affect the outcome of the metabolic disturbances
on the fetus.
5. Conclusions
We have demonstrated in Min/+ mice that the intrauterine
and nursing period is a window of susceptibility for exposure
to a high fat diet for development of obesity, and also that
this obesogenic exposure has direct adverse health effects,
that is, increased intestinal tumorigenesis, in the offspring as
adults. Disturbed blood glucose regulation does not appear to
be involved in this association between obesity and intestinal
tumorigenesis.
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